Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein serine kinase activity	CAMK2G LRRK1 HUNK MAST2 STK35 CIT MAST4 CSNK1D MARK4 MAST1 ROCK1 EIF2AK3 PLK3 WNK2 MAST3 MAP3K2	1.16e-07	363	173	16	GO:0106310
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	CAMK2G LRRK1 HUNK MAST2 STK35 CIT MAST4 CSNK1D MARK4 MAST1 ROCK1 LTBP1 EIF2AK3 PLK3 WNK2 MAST3 MAP3K2	3.61e-07	446	173	17	GO:0004674
GeneOntologyMolecularFunction	microtubule binding	MAP2 KIF26B NUMA1 CAMSAP3 KIF12 MAST2 CCDC61 JMY GAS2L1 STARD9 MARK4 MAST1 FMN2 DNM1	5.13e-07	308	173	14	GO:0008017
GeneOntologyMolecularFunction	tubulin binding	MAP2 KIF26B BCAS3 NUMA1 CAMSAP3 KIF12 MAST2 CCDC61 JMY GAS2L1 STARD9 MARK4 MAST1 FMN2 DNM1	5.06e-06	428	173	15	GO:0015631
GeneOntologyMolecularFunction	cytoskeletal protein binding	BICD2 ANK3 MAP2 SYNM KIF26B BCAS3 MTSS1 NUMA1 CAMSAP3 KIF12 SYNPO MAST2 CCDC61 JMY GAS2L1 STARD9 SIPA1L1 MARK4 MYO1F MAST1 FMN2 ROCK1 SSH2 PLEKHH2 DNM1	9.30e-06	1099	173	25	GO:0008092
GeneOntologyMolecularFunction	protein kinase activity	CAMK2G LRRK1 HUNK MAST2 STK35 CIT MAST4 CSNK1D MARK4 MAST1 ROCK1 LTBP1 EIF2AK3 PLK3 WNK2 MAST3 MAP3K2	1.91e-05	600	173	17	GO:0004672
GeneOntologyMolecularFunction	cytoskeletal anchor activity	BICD2 ANK3 GAS2L1 MARK4	5.05e-05	24	173	4	GO:0008093
GeneOntologyMolecularFunction	molecular adaptor activity	DAB2IP SHANK1 BICD2 ANK3 SYNM PHF12 BCORL1 FRS3 DVL3 AMBRA1 ZC3H18 RUFY1 HDAC7 JMY GAS2L1 TDRD3 DLGAP3 MAVS BAZ2A MARK4 EIF4G1 FGF2 LTBP1 RIMS2 TP53BP1 TNS3	1.10e-04	1356	173	26	GO:0060090
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	CAMK2G LRRK1 HUNK MAST2 STK35 CIT MAST4 CSNK1D MARK4 MAST1 ROCK1 LTBP1 EIF2AK3 PLK3 WNK2 MAST3 MAP3K2	1.50e-04	709	173	17	GO:0016773
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	DAB2IP SHANK1 BICD2 ANK3 SYNM PHF12 BCORL1 FRS3 DVL3 AMBRA1 ZC3H18 RUFY1 HDAC7 JMY GAS2L1 TDRD3 MAVS BAZ2A MARK4 FGF2 RIMS2 TP53BP1 TNS3	1.76e-04	1160	173	23	GO:0030674
GeneOntologyMolecularFunction	kinase activity	CAMK2G LRRK1 HUNK MAST2 STK35 CIT MAST4 CSNK1D MARK4 MAST1 ROCK1 LTBP1 EIF2AK3 PLK3 WNK2 MAST3 MAP3K2	3.58e-04	764	173	17	GO:0016301
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	CAMK2G LRRK1 HUNK MAST2 TERT STK35 CIT MAST4 CSNK1D MARK4 MAST1 ROCK1 LTBP1 EIF2AK3 PLK3 PIGO WNK2 MAST3 MAP3K2	5.15e-04	938	173	19	GO:0016772
GeneOntologyMolecularFunction	protein domain specific binding	DAB2IP SHANK1 NUMA1 EBF1 PLXND1 RUFY1 CIT TAMALIN CEP68 HEYL DLGAP3 MAVS ERC2 DNM1 RIMS2 SRRM2 LNX1 INPP5J	6.07e-04	875	173	18	GO:0019904
GeneOntologyMolecularFunction	tau-protein kinase activity	CSNK1D MARK4 ROCK1	8.72e-04	22	173	3	GO:0050321
GeneOntologyMolecularFunction	eukaryotic translation initiation factor 2alpha kinase activity	STK35 EIF2AK3	1.09e-03	6	173	2	GO:0004694
GeneOntologyMolecularFunction	SH3 domain binding	DAB2IP SHANK1 RUFY1 CIT DNM1 INPP5J	1.56e-03	143	173	6	GO:0017124
GeneOntologyBiologicalProcess	regulation of cytoskeleton organization	SHANK1 BICD2 SLAIN2 MAP2 BCAS3 ARHGEF5 MTSS1 NUMA1 CAMSAP3 DVL3 SYNPO CIT GAS2L1 PHLDB1 MYO1F ROCK1 SSH2 PLEKHH2 INPP5J	5.19e-07	579	175	19	GO:0051493
GeneOntologyBiologicalProcess	positive regulation of mRNA splicing, via spliceosome	RBMY1A1 RBMY1C RBMY1D RBMY1B RBMY1E RBMY1F	1.85e-06	44	175	6	GO:0048026
GeneOntologyBiologicalProcess	regulation of organelle organization	SHANK1 BICD2 SLAIN2 MAP2 BCAS3 ARHGEF5 ENTR1 MTSS1 NUMA1 CAMSAP3 DVL3 AMBRA1 SYNPO CIT GAS2L1 PHLDB1 LMNA MAVS SIPA1L1 MARK4 MYO1F MKI67 ERC2 ROCK1 SSH2 PLEKHH2 RIMS2 USP6NL INPP5J	3.01e-06	1342	175	29	GO:0033043
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization	BICD2 SLAIN2 ANK3 MAP2 NUMA1 CAMSAP3 CCDC61 CEP68 GAS2L1 PHLDB1 MAP7D1 LMNA CSNK1D STARD9 MARK4 PKHD1 FMN2 ROCK1 PLK3 INPP5J	3.35e-06	720	175	20	GO:0000226
GeneOntologyBiologicalProcess	positive regulation of mRNA processing	RBMY1A1 RBMY1C RBMY1D RBMY1B RBMY1E RBMY1F	3.54e-06	49	175	6	GO:0050685
GeneOntologyBiologicalProcess	establishment or maintenance of microtubule cytoskeleton polarity	ANK3 CAMSAP3 LMNA	5.93e-06	5	175	3	GO:0030951
GeneOntologyBiologicalProcess	positive regulation of RNA splicing	RBMY1A1 RBMY1C RBMY1D RBMY1B RBMY1E RBMY1F	1.56e-05	63	175	6	GO:0033120
GeneOntologyBiologicalProcess	cell junction maintenance	SHANK1 MTSS1 CAMSAP3 ERC2 RIMS2 ADGRL3	1.87e-05	65	175	6	GO:0034331
GeneOntologyBiologicalProcess	regulation of microtubule cytoskeleton organization	BICD2 SLAIN2 MAP2 NUMA1 CAMSAP3 GAS2L1 PHLDB1 ROCK1 INPP5J	2.00e-05	176	175	9	GO:0070507
GeneOntologyBiologicalProcess	regulation of supramolecular fiber organization	SHANK1 SLAIN2 MAP2 ARHGEF5 MTSS1 NUMA1 CAMSAP3 SYNPO CIT GAS2L1 ROCK1 SSH2 PLEKHH2 INPP5J	2.35e-05	438	175	14	GO:1902903
GeneOntologyBiologicalProcess	regulation of microtubule-based process	BICD2 SLAIN2 MAP2 NUMA1 CAMSAP3 GAS2L1 PHLDB1 MARK4 PKHD1 ROCK1 INPP5J	4.30e-05	293	175	11	GO:0032886
GeneOntologyBiologicalProcess	establishment or maintenance of cytoskeleton polarity	ANK3 CAMSAP3 LMNA	4.86e-05	9	175	3	GO:0030952
GeneOntologyBiologicalProcess	regulation of mRNA processing	RBMY1A1 RBMY1C RBMY1D RBMY1B RBMY1E HDAC7 PABPN1 RBMY1F	6.25e-05	158	175	8	GO:0050684
GeneOntologyBiologicalProcess	cell cycle process	DAB2IP DONSON ANK3 CAMK2G ENTR1 NUMA1 CAMSAP3 CCNO AMBRA1 TERT CIT CCDC61 CEP68 LMNA USP51 CSNK1D STARD9 MARK4 EIF4G1 CTDP1 MKI67 PKHD1 FMN2 ROCK1 CDT1 PLK3 TP53BP1	8.39e-05	1441	175	27	GO:0022402
GeneOntologyBiologicalProcess	microtubule-based process	BICD2 SLAIN2 ANK3 MAP2 KIF26B NUMA1 CAMSAP3 KIF12 CCDC61 CEP68 GAS2L1 PHLDB1 MAP7D1 LMNA CSNK1D STARD9 MARK4 PKHD1 FMN2 ROCK1 PLK3 INPP5J	9.38e-05	1058	175	22	GO:0007017
GeneOntologyBiologicalProcess	cellular component maintenance	SHANK1 MTSS1 CAMSAP3 ERC2 RIMS2 ADGRL3	2.23e-04	101	175	6	GO:0043954
GeneOntologyBiologicalProcess	cell junction organization	DAB2IP SHANK1 CACNA1A ANK3 MTSS1 CAMSAP3 SYNPO PLXND1 HDAC7 ARHGAP22 DLGAP3 SIPA1L1 EIF4G1 PKHD1 ERC2 ROCK1 IGSF9B RIMS2 LNX1 ADGRL3	2.35e-04	974	175	20	GO:0034330
GeneOntologyBiologicalProcess	synapse organization	DAB2IP SHANK1 CACNA1A ANK3 SYNPO PLXND1 ARHGAP22 DLGAP3 SIPA1L1 EIF4G1 ERC2 ROCK1 IGSF9B RIMS2 LNX1 ADGRL3	2.51e-04	685	175	16	GO:0050808
GeneOntologyCellularComponent	somatodendritic compartment	DAB2IP SHANK1 CACNA1A CNTNAP3B ANK3 MAP2 INHA NUMA1 CNTNAP3 SYNPO CIT DLGAP3 SIPA1L1 MARK4 MAST1 ERC2 CACNA1G LTBP1 IGSF9B TMEM151A PLK3 INPP5J AGAP2 PRPH	9.37e-05	1228	175	24	GO:0036477
GeneOntologyCellularComponent	neuronal cell body	DAB2IP CACNA1A CNTNAP3B MAP2 INHA NUMA1 CNTNAP3 SYNPO CIT DLGAP3 SIPA1L1 MAST1 ERC2 CACNA1G LTBP1 IGSF9B PLK3 PRPH	2.33e-04	835	175	18	GO:0043025
GeneOntologyCellularComponent	microtubule organizing center	BICD2 SLAIN2 ENTR1 NUMA1 CAMSAP3 CCNO KIF12 DENND1C CCDC61 CEP68 PLEKHG6 CSNK1D STARD9 KIAA1217 MARK4 CTDP1 PKHD1 ROCK1 PLK3	2.64e-04	919	175	19	GO:0005815
GeneOntologyCellularComponent	microtubule end	SLAIN2 NUMA1 CAMSAP3 GAS2L1	2.80e-04	38	175	4	GO:1990752
GeneOntologyCellularComponent	cell body	DAB2IP CACNA1A CNTNAP3B MAP2 INHA NUMA1 CNTNAP3 SYNPO PLXND1 CIT DLGAP3 SIPA1L1 MAST1 ERC2 CACNA1G LTBP1 IGSF9B PLK3 PRPH	3.02e-04	929	175	19	GO:0044297
GeneOntologyCellularComponent	dendrite	DAB2IP SHANK1 CACNA1A ANK3 MAP2 NUMA1 SYNPO DLGAP3 SIPA1L1 MARK4 MAST1 CACNA1G LTBP1 IGSF9B TMEM151A PLK3 INPP5J AGAP2	3.23e-04	858	175	18	GO:0030425
GeneOntologyCellularComponent	dendritic tree	DAB2IP SHANK1 CACNA1A ANK3 MAP2 NUMA1 SYNPO DLGAP3 SIPA1L1 MARK4 MAST1 CACNA1G LTBP1 IGSF9B TMEM151A PLK3 INPP5J AGAP2	3.32e-04	860	175	18	GO:0097447
GeneOntologyCellularComponent	cell cortex region	NUMA1 PHLDB1 ERC2 RIMS2	5.41e-04	45	175	4	GO:0099738
GeneOntologyCellularComponent	nuclear body	SETD1A ZC3H13 ZC3H18 RUFY1 TERT STK35 LMNA BAZ2A PABPN1 MKI67 NHS CDT1 KAZN PLEKHH2 SRRM2 HECTD1 PRDM15 TP53BP1	5.91e-04	903	175	18	GO:0016604
GeneOntologyCellularComponent	centrosome	BICD2 SLAIN2 ENTR1 NUMA1 CAMSAP3 CCNO DENND1C CCDC61 CEP68 PLEKHG6 CSNK1D KIAA1217 MARK4 CTDP1 PKHD1 PLK3	7.75e-04	770	175	16	GO:0005813
GeneOntologyCellularComponent	supramolecular fiber	SLAIN2 ANK3 MAP2 SYNM KIF26B BCAS3 NUMA1 CAMSAP3 KIF12 SYNPO RTN2 GAS2L1 FBXL22 LMNA CSNK1D MYO1F FMN2 LTBP1 DNM1 CEP170B PRPH	8.89e-04	1179	175	21	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	SLAIN2 ANK3 MAP2 SYNM KIF26B BCAS3 NUMA1 CAMSAP3 KIF12 SYNPO RTN2 GAS2L1 FBXL22 LMNA CSNK1D MYO1F FMN2 LTBP1 DNM1 CEP170B PRPH	9.69e-04	1187	175	21	GO:0099081
GeneOntologyCellularComponent	nuclear speck	SETD1A ZC3H13 ZC3H18 RUFY1 TERT LMNA BAZ2A PABPN1 KAZN SRRM2 HECTD1	1.05e-03	431	175	11	GO:0016607
GeneOntologyCellularComponent	microtubule minus-end	NUMA1 CAMSAP3	1.42e-03	7	175	2	GO:0036449
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	SLAIN2 MAP2 SYNM KIF26B BCAS3 NUMA1 CAMSAP3 KIF12 RTN2 GAS2L1 LMNA CSNK1D MYO1F FMN2 DNM1 CEP170B PRPH	1.49e-03	899	175	17	GO:0099513
GeneOntologyCellularComponent	microtubule plus-end	SLAIN2 NUMA1 GAS2L1	1.62e-03	28	175	3	GO:0035371
GeneOntologyCellularComponent	cytoskeleton of presynaptic active zone	ERC2 RIMS2	1.89e-03	8	175	2	GO:0048788
Domain	RBM1CTR	RBMY1A1 RBMY1D RBMY1B RBMY1E RBMY1F	3.32e-09	8	171	5	PF08081
Domain	RBM1CTR	RBMY1A1 RBMY1D RBMY1B RBMY1E RBMY1F	3.32e-09	8	171	5	IPR012604
Domain	DUF1908	MAST2 MAST4 MAST1 MAST3	6.79e-09	4	171	4	PF08926
Domain	MA_Ser/Thr_Kinase_dom	MAST2 MAST4 MAST1 MAST3	6.79e-09	4	171	4	IPR015022
Domain	MAST_pre-PK_dom	MAST2 MAST4 MAST1 MAST3	6.79e-09	4	171	4	IPR023142
Domain	-	MAST2 MAST4 MAST1 MAST3	6.79e-09	4	171	4	1.20.1480.20
Domain	Ser/Thr_kinase_AS	CAMK2G LRRK1 HUNK MAST2 STK35 CIT MAST4 CSNK1D MARK4 MAST1 ROCK1 EIF2AK3 PLK3 WNK2 MAST3 MAP3K2	1.92e-07	357	171	16	IPR008271
Domain	S_TKc	CAMK2G LRRK1 HUNK MAST2 STK35 CIT MAST4 CSNK1D MARK4 MAST1 ROCK1 EIF2AK3 PLK3 WNK2 MAST3 MAP3K2	2.07e-07	359	171	16	SM00220
Domain	PROTEIN_KINASE_ST	CAMK2G LRRK1 HUNK MAST2 STK35 CIT MAST4 CSNK1D MARK4 MAST1 ROCK1 EIF2AK3 PLK3 WNK2 MAST3 MAP3K2	2.32e-07	362	171	16	PS00108
Domain	Pkinase	CAMK2G LRRK1 HUNK MAST2 STK35 CIT MAST4 CSNK1D MARK4 MAST1 ROCK1 EIF2AK3 PLK3 WNK2 MAST3 MAP3K2	4.60e-07	381	171	16	PF00069
Domain	PDZ	SHANK1 DVL3 MAST2 TAMALIN MAST4 SIPA1L1 MAST1 RIMS2 LNX1 MAST3	7.00e-07	141	171	10	PF00595
Domain	PDZ	SHANK1 DVL3 MAST2 TAMALIN MAST4 SIPA1L1 MAST1 RIMS2 LNX1 MAST3	1.09e-06	148	171	10	SM00228
Domain	-	SHANK1 DVL3 MAST2 TAMALIN MAST4 SIPA1L1 MAST1 RIMS2 LNX1 MAST3	1.23e-06	150	171	10	2.30.42.10
Domain	PDZ	SHANK1 DVL3 MAST2 TAMALIN MAST4 SIPA1L1 MAST1 RIMS2 LNX1 MAST3	1.31e-06	151	171	10	PS50106
Domain	PDZ	SHANK1 DVL3 MAST2 TAMALIN MAST4 SIPA1L1 MAST1 RIMS2 LNX1 MAST3	1.39e-06	152	171	10	IPR001478
Domain	Kinase-like_dom	CAMK2G WDR81 LRRK1 HUNK MAST2 STK35 CIT MAST4 CSNK1D MARK4 MAST1 ROCK1 DNM1 EIF2AK3 PLK3 WNK2 MAST3 MAP3K2	2.55e-06	542	171	18	IPR011009
Domain	PROTEIN_KINASE_ATP	CAMK2G LRRK1 HUNK MAST2 STK35 CIT MAST4 CSNK1D MARK4 MAST1 ROCK1 EIF2AK3 PLK3 WNK2 MAST3 MAP3K2	5.16e-06	459	171	16	PS00107
Domain	PH	DAB2IP ARHGEF5 GRB7 CIT ARHGAP22 PHLDB1 PLEKHG6 PLCH2 ROCK1 PLEKHH2 DNM1 AGAP2	1.01e-05	278	171	12	SM00233
Domain	PH_DOMAIN	DAB2IP ARHGEF5 GRB7 CIT ARHGAP22 PHLDB1 PLEKHG6 PLCH2 ROCK1 PLEKHH2 DNM1 AGAP2	1.04e-05	279	171	12	PS50003
Domain	PH_domain	DAB2IP ARHGEF5 GRB7 CIT ARHGAP22 PHLDB1 PLEKHG6 PLCH2 ROCK1 PLEKHH2 DNM1 AGAP2	1.08e-05	280	171	12	IPR001849
Domain	Prot_kinase_dom	CAMK2G LRRK1 HUNK MAST2 STK35 CIT MAST4 CSNK1D MARK4 MAST1 ROCK1 EIF2AK3 PLK3 WNK2 MAST3 MAP3K2	1.14e-05	489	171	16	IPR000719
Domain	AGC-kinase_C	MAST2 CIT MAST4 MAST1 ROCK1 MAST3	1.20e-05	56	171	6	IPR000961
Domain	AGC_KINASE_CTER	MAST2 CIT MAST4 MAST1 ROCK1 MAST3	1.20e-05	56	171	6	PS51285
Domain	S_TK_X	MAST2 CIT MAST4 MAST1 ROCK1 MAST3	1.20e-05	56	171	6	SM00133
Domain	PROTEIN_KINASE_DOM	CAMK2G LRRK1 HUNK MAST2 STK35 CIT MAST4 CSNK1D MARK4 MAST1 ROCK1 EIF2AK3 PLK3 WNK2 MAST3 MAP3K2	1.26e-05	493	171	16	PS50011
Domain	-	DAB2IP ARHGEF5 FRS3 GRB7 CIT ARHGAP22 PHLDB1 PLEKHG6 PLCH2 ROCK1 PLEKHH2 DNM1 TNS3 AGAP2	1.52e-05	391	171	14	2.30.29.30
Domain	-	PHF12 PHLDB1 STARD9 MKI67 CEP170B	1.82e-05	36	171	5	2.60.200.20
Domain	FHA_dom	PHF12 PHLDB1 STARD9 MKI67 CEP170B	1.82e-05	36	171	5	IPR000253
Domain	PH_dom-like	DAB2IP ARHGEF5 FRS3 GRB7 CIT ARHGAP22 PHLDB1 PLEKHG6 PLCH2 ROCK1 PLEKHH2 DNM1 TNS3 AGAP2	3.92e-05	426	171	14	IPR011993
Domain	Pkinase_C	MAST2 CIT MAST1 ROCK1 MAST3	3.92e-05	42	171	5	PF00433
Domain	PH	ARHGEF5 GRB7 CIT ARHGAP22 PHLDB1 PLCH2 ROCK1 PLEKHH2 DNM1 AGAP2	5.09e-05	229	171	10	PF00169
Domain	SMAD_FHA_domain	PHF12 PHLDB1 STARD9 MKI67 CEP170B	1.11e-04	52	171	5	IPR008984
Domain	FHA_DOMAIN	PHF12 PHLDB1 MKI67 CEP170B	1.76e-04	31	171	4	PS50006
Domain	FHA	PHLDB1 STARD9 MKI67 CEP170B	1.76e-04	31	171	4	PF00498
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SLAIN2 MAP2 KIF26B BCAS3 ARHGEF5 SPATA18 CAMSAP3 MAST2 HDAC7 GLCCI1 PHLDB1 MAP7D1 MAST4 CSNK1D STARD9 KIAA1217 SIPA1L1 MARK4 EIF4G1 FMN2 NHS SSH2 SRRM2 HECTD1 PCDH7 USP6NL CEP170B TNS3 MAP3K2	2.65e-15	861	185	29	36931259
Pubmed	A Y chromosome gene family with RNA-binding protein homology: candidates for the azoospermia factor AZF controlling human spermatogenesis.	RBMY1A1 RBMY1C RBMY1D RBMY1B RBMY1E RBMY1F	1.46e-13	7	185	6	8269511
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	DAB2IP SHANK1 CACNA1A NYAP2 ANK3 PRR36 CAMK2G NUMA1 CAMSAP3 WDR81 SYNPO CIT TDRD3 DLGAP3 MAP7D1 KIAA1217 SIPA1L1 EIF4G1 ERC2 ROCK1 SSH2 DNM1 CEP170B WNK2 TP53BP1 STOML2 AGAP2	1.96e-12	963	185	27	28671696
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	DAB2IP CACNA1A MAP2 BCAS3 CAMK2G CAMSAP3 SYNPO CIT GLCCI1 SIPA1L1 FMN2 ERC2 RIMS2 SRRM2 CEP170B ADGRL3 AGAP2	6.56e-12	347	185	17	17114649
Pubmed	Structure and organization of the RBMY genes on the human Y chromosome: transposition and amplification of an ancestral autosomal hnRNPG gene.	RBMY1A1 RBMY1C RBMY1D RBMY1B RBMY1E RBMY1F	1.88e-11	12	185	6	9598316
Pubmed	RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts.	RBMY1A1 RBMY1D RBMY1B RBMY1E RBMY1F	2.41e-11	6	185	5	15184870
Pubmed	Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene.	RBMY1A1 RBMY1D RBMY1B RBMY1E RBMY1F	8.40e-11	7	185	5	8875892
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	DAB2IP SHANK1 ANK3 CAMK2G CAMSAP3 SYNPO CIT DLGAP3 SIPA1L1 DNM1 RIMS2 PCDH7 CEP170B AGAP2	4.06e-10	281	185	14	28706196
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	DAB2IP SHANK1 BICD2 CACNA1A NYAP2 ANK3 MAP2 BCAS3 CAMK2G CAMSAP3 DVL3 SYNPO CIT DLGAP3 LMNA KIAA1217 SIPA1L1 DLAT MTX1 CEP170B ELP4 ADGRL3 WNK2 TP53BP1 STOML2 AGAP2	4.52e-10	1139	185	26	36417873
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SHANK1 CACNA1A ANK3 MAP2 PRR36 BCAS3 CAMK2G CAMSAP3 SYNPO CIT JMY GAS2L1 DLGAP3 PHLDB1 MAP7D1 LMNA CSNK1D KIAA1217 SIPA1L1 EIF4G1 MAST1 DLAT ERC2 SSH2 DNM1 CEP170B WNK2 STOML2 AGAP2	6.33e-10	1431	185	29	37142655
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	DAB2IP SETD1A BCAS3 PHF12 MEX3D THAP8 AMBRA1 LRRK1 PLXND1 MAST2 CIT HDAC7 GAS2L1 HEYL TDRD3 PHLDB1 MARK4 EIF4G1 CTDP1 TXNRD3 ANKRD34A HECTD1 PLK3 CEP170B WNK2	1.21e-09	1105	185	25	35748872
Pubmed	An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells.	RBMY1A1 RBMY1D RBMY1B RBMY1E	3.86e-09	5	185	4	8817321
Pubmed	Human RBMY regulates germline-specific splicing events by modulating the function of the serine/arginine-rich proteins 9G8 and Tra2-{beta}.	RBMY1A1 RBMY1D RBMY1B RBMY1E	3.86e-09	5	185	4	20016065
Pubmed	The role of human and mouse Y chromosome genes in male infertility.	RBMY1A1 RBMY1D RBMY1B RBMY1E	3.86e-09	5	185	4	11097427
Pubmed	Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability.	RBMY1A1 RBMY1D RBMY1B RBMY1E	3.86e-09	5	185	4	19737860
Pubmed	Identification of target messenger RNA substrates for mouse RBMY.	RBMY1A1 RBMY1D RBMY1B RBMY1E	1.15e-08	6	185	4	18492746
Pubmed	Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist.	RBMY1A1 RBMY1D RBMY1B RBMY1E	1.15e-08	6	185	4	12356914
Pubmed	Mouse homologues of the human AZF candidate gene RBM are expressed in spermatogonia and spermatids, and map to a Y chromosome deletion interval associated with a high incidence of sperm abnormalities.	RBMY1A1 RBMY1D RBMY1B RBMY1E	1.15e-08	6	185	4	9499427
Pubmed	The behavior of the X- and Y-chromosomes in the oocyte during meiotic prophase in the B6.Y(TIR)sex-reversed mouse ovary.	RBMY1A1 RBMY1D RBMY1B RBMY1E	1.15e-08	6	185	4	18239052
Pubmed	Does Rbmy have a role in sperm development in mice?	RBMY1A1 RBMY1D RBMY1B RBMY1E	1.15e-08	6	185	4	15051956
Pubmed	The roles of RNA-binding proteins in spermatogenesis and male infertility.	RBMY1A1 RBMY1D RBMY1B RBMY1E	2.68e-08	7	185	4	10377282
Pubmed	RNA-binding motif protein 15 binds to the RNA transport element RTE and provides a direct link to the NXF1 export pathway.	RBMY1A1 RBMY1D RBMY1B RBMY1E	2.68e-08	7	185	4	17001072
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	MAP2 CAMK2G SYNPO CIT LMNA SIPA1L1 RIMS2 SRRM2 CEP170B MAST3 AGAP2	5.11e-08	231	185	11	16452087
Pubmed	Y chromosome short arm-Sxr recombination in XSxr/Y males causes deletion of Rbm and XY female sex reversal.	RBMY1A1 RBMY1D RBMY1B RBMY1E	5.34e-08	8	185	4	7479793
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	DAB2IP SHANK1 PHF12 CAMK2G FRS3 DVL3 SYNPO ARHGAP22 DLGAP3 PHLDB1 PABPN1 CSNK1D SIPA1L1 LTBP1 KAZN ADAMTSL4	6.24e-08	560	185	16	21653829
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	DAB2IP CAMSAP3 SYNPO DLGAP3 CSNK1D STARD9 SIPA1L1 MARK4 MYO1F MAST1 CEP170B STOML2 AGAP2 PRPH	8.86e-08	430	185	14	32581705
Pubmed	Mice with Y chromosome deletion and reduced Rbm genes on a heterozygous Dazl1 null background mimic a human azoospermic factor phenotype.	RBMY1A1 RBMY1D RBMY1B RBMY1E	1.59e-07	10	185	4	10601091
Pubmed	Characterisation of the coding sequence and fine mapping of the human DFFRY gene and comparative expression analysis and mapping to the Sxrb interval of the mouse Y chromosome of the Dffry gene.	RBMY1A1 RBMY1D RBMY1B RBMY1E	1.59e-07	10	185	4	9384609
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SLAIN2 SETD1A NYAP2 PHF12 MTSS1 AMBRA1 SYNPO LRRK1 PLXND1 MAST4 PLCH2 CACNA1G RIMS2 USP6NL WNK2	1.81e-07	529	185	15	14621295
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	BICD2 PHF12 ZC3H13 NUMA1 CAMSAP3 TATDN2 ZC3H18 HDAC7 LMNA BAZ2A SIPA1L1 EIF4G1 CTDP1 MKI67 CDT1 SRRM2 PCDH7 TP53BP1	1.98e-07	774	185	18	15302935
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	BICD2 NYAP2 MEX3D TDRD3 PHLDB1 SIPA1L1 MYO1F ERC2 CEP170B STOML2	2.96e-07	218	185	10	33378226
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DAB2IP BICD2 PHLDB1 MAP7D1 BAZ2A STARD9 SIPA1L1 MARK4 MAST1 ERC2 SRRM2 CEP170B ADGRL3	3.22e-07	407	185	13	12693553
Pubmed	The role of Dby mRNA in early development of male mouse zygotes.	RBMY1A1 RBMY1D RBMY1B RBMY1E	3.71e-07	12	185	4	20543856
Pubmed	GASZ promotes germ cell derivation from embryonic stem cells.	RBMY1A1 RBMY1D RBMY1B RBMY1E	5.34e-07	13	185	4	23816659
Pubmed	RBMY, a probable human spermatogenesis factor, and other hnRNP G proteins interact with Tra2beta and affect splicing.	RBMY1A1 RBMY1C RBMY1B RBMY1F	5.34e-07	13	185	4	10749975
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	CACNA1A BCAS3 MAP7D1 STARD9 MKI67 ANKRD34A MAST1 SRRM2 WNK2 TNS3	5.46e-07	233	185	10	37704626
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	DAB2IP BICD2 ZC3H13 NUMA1 CAMSAP3 GLCCI1 LMNA MAVS EIF4G1 CTDP1 MKI67 NHS SRRM2 TP53BP1	5.86e-07	503	185	14	16964243
Pubmed	Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases.	MAST2 MAST1 MAST3	5.90e-07	4	185	3	15951562
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	PHF12 ZC3H13 NUMA1 CAMSAP3 SYNPO ZC3H18 MAP7D1 STARD9 KIAA1217 MKI67 SRRM2 MAST3	6.09e-07	361	185	12	30344098
Pubmed	Absence of mDazl produces a final block on germ cell development at meiosis.	RBMY1A1 RBMY1D RBMY1B RBMY1E	7.44e-07	14	185	4	14611631
Pubmed	PDZ-Containing Proteins Targeted by the ACE2 Receptor.	SHANK1 MAST2 TAMALIN MAST1	1.01e-06	15	185	4	34835087
Pubmed	Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome.	RBMY1A1 RBMY1D RBMY1B RBMY1E	1.01e-06	15	185	4	14762062
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	DAB2IP SHANK1 ANK3 CAMK2G SYNPO CIT DLGAP3 ERC2 DNM1 AGAP2	1.07e-06	251	185	10	27507650
Pubmed	Loss of maternal Trim28 causes male-predominant early embryonic lethality.	RBMY1A1 RBMY1D RBMY1B RBMY1E	1.75e-06	17	185	4	28115466
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	KIF26B ENTR1 TDRD3 MAST4 SIPA1L1 NHS HECTD1 CEP170B TNS3	1.98e-06	209	185	9	36779422
Pubmed	Sex differences in sex chromosome gene expression in mouse brain.	RBMY1A1 RBMY1D RBMY1B RBMY1E	2.24e-06	18	185	4	12023983
Pubmed	Ectopic expression of luteinizing hormone-releasing hormone and peripherin in the respiratory epithelium of mice lacking transcription factor AP-2alpha.	EBF1 MKI67 PRPH	2.93e-06	6	185	3	10842061
Pubmed	Rebuilding essential active zone functions within a synapse.	CACNA1A ERC2 RIMS2	5.10e-06	7	185	3	35176221
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	SHANK1 BICD2 ANK3 SYNM DVL3 SYNPO HUNK CIT ZNF785 ZBTB44 SIPA1L1 EIF4G1 MAST1 FMN2 DLEU7 DLAT ERC2 DNM1 LNX1 HECTD1 AGAP2	5.46e-06	1285	185	21	35914814
Pubmed	MRNIP interacts with sex body chromatin to support meiotic progression, spermatogenesis, and male fertility in mice.	RBMY1A1 RBMY1D RBMY1B RBMY1E	1.06e-05	26	185	4	35920200
Pubmed	Zfhx3 is required for the differentiation of late born D1-type medium spiny neurons.	CNTNAP3B CNTNAP3 EBF1 MKI67	1.66e-05	29	185	4	31491374
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	ARHGEF5 GRB7 HDAC7 SIPA1L1 SRRM2 MAP3K2	1.84e-05	102	185	6	15778465
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	SETD1A SYNM MAST4 BAZ2A ERC2 SRRM2	2.06e-05	104	185	6	9205841
Pubmed	EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions.	SLAIN2 CAMK2G GAS2L1 LMNA KIAA1217	2.21e-05	63	185	5	29162697
Pubmed	Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.	SLAIN2 SYNPO GAS2L1 PHLDB1 DNM1 SRRM2	2.55e-05	108	185	6	19531213
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	ANK3 ZC3H13 ZC3H18 MAST2 PHLDB1 MAP7D1 LMNA EIF4G1 SRRM2 TNS3	2.60e-05	361	185	10	26167880
Pubmed	Identification of human protein interaction domains using an ORFeome-based yeast two-hybrid fragment library.	NUMA1 DVL3 LNX1 PRPH	2.81e-05	33	185	4	23718855
Pubmed	Caspr3-Deficient Mice Exhibit Low Motor Learning during the Early Phase of the Accelerated Rotarod Task.	CNTNAP3B CNTNAP3	2.81e-05	2	185	2	26807827
Pubmed	UVA-induced upregulation of progerin suppresses 53BP1‑mediated NHEJ DSB repair in human keratinocytes via progerin-lamin A complex formation.	LMNA TP53BP1	2.81e-05	2	185	2	28498430
Pubmed	NuMA1 promotes axon initial segment assembly through inhibition of endocytosis.	ANK3 NUMA1	2.81e-05	2	185	2	31727776
Pubmed	Regulatory cross-talk determines the cellular levels of 53BP1 protein, a critical factor in DNA repair.	LMNA TP53BP1	2.81e-05	2	185	2	28255090
Pubmed	TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors.	TERT MKI67	2.81e-05	2	185	2	28150740
Pubmed	[Correlation of hTERT expression to maspin and bFGF expression and their significance in glioma].	TERT FGF2	2.81e-05	2	185	2	17562265
Pubmed	The nuclear structural protein NuMA is a negative regulator of 53BP1 in DNA double-strand break repair.	NUMA1 TP53BP1	2.81e-05	2	185	2	30812030
Pubmed	The hTERT-protein and Ki-67 labelling index in recurrent and non-recurrent meningiomas.	TERT MKI67	2.81e-05	2	185	2	15679862
Pubmed	Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis.	RBMY1A1 RBMY1B	2.81e-05	2	185	2	32473614
Pubmed	The critical role of ASD-related gene CNTNAP3 in regulating synaptic development and social behavior in mice.	CNTNAP3B CNTNAP3	2.81e-05	2	185	2	31150793
Pubmed	A conserved CCCH-type zinc finger protein regulates mRNA nuclear adenylation and export.	ZC3H3 PABPN1	2.81e-05	2	185	2	19364924
Pubmed	Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer.	EBF1 TERT	2.81e-05	2	185	2	32364535
Pubmed	Depletion of A-type lamins and Lap2α reduces 53BP1 accumulation at UV-induced DNA lesions and Lap2α protein is responsible for compactness of irradiated chromatin.	LMNA TP53BP1	2.81e-05	2	185	2	29923310
Pubmed	Subthreshold membrane potential oscillations in inferior olive neurons are dynamically regulated by P/Q- and T-type calcium channels: a study in mutant mice.	CACNA1A CACNA1G	2.81e-05	2	185	2	20547676
Pubmed	Lamin A/C-dependent interaction with 53BP1 promotes cellular responses to DNA damage.	LMNA TP53BP1	2.81e-05	2	185	2	25645366
Pubmed	Upregulation of h-TERT and Ki-67 in ectopic endometrium is associated with recurrence of endometriosis.	TERT MKI67	2.81e-05	2	185	2	35187889
Pubmed	Decreased Anxiety-Related Behaviour but Apparently Unperturbed NUMB Function in Ligand of NUMB Protein-X (LNX) 1/2 Double Knockout Mice.	PHLDB1 ERC2 KAZN LNX1 CEP170B AGAP2	2.83e-05	110	185	6	27889896
Pubmed	CAMSAP1 breaks the homeostatic microtubule network to instruct neuronal polarity.	MAP2 CAMSAP3 MKI67	3.14e-05	12	185	3	32839317
Pubmed	Rewiring of RSK-PDZ Interactome by Linear Motif Phosphorylation.	MAST2 TAMALIN MAST1 LNX1	3.17e-05	34	185	4	30726710
Pubmed	Myotubularin-related proteins 3 and 4 interact with polo-like kinase 1 and centrosomal protein of 55 kDa to ensure proper abscission.	BICD2 ANK3 ENTR1 SPATA18 DVL3 TP53BP1 STOML2	3.33e-05	167	185	7	25659891
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	SLAIN2 PRR36 ARHGEF5 CAMK2G NUMA1 CAMSAP3 ARHGAP22 MAP7D1 PLEKHG6 LMNA PABPN1 CSNK1D SP6 DLAT KAZN STOML2	3.46e-05	916	185	16	32203420
Pubmed	Interactome Analysis Reveals Regulator of G Protein Signaling 14 (RGS14) is a Novel Calcium/Calmodulin (Ca2+/CaM) and CaM Kinase II (CaMKII) Binding Partner.	SHANK1 ANK3 CAMK2G SYNPO DLGAP3 ERC2 AGAP2 PRPH	3.80e-05	233	185	8	29518331
Pubmed	Reticulons 1 and 3 are essential for axonal growth and synaptic maintenance associated with intellectual development.	MAP2 RTN2 MKI67	4.07e-05	13	185	3	37228035
Pubmed	A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response.	FTMT CIT GLCCI1 KIAA1217 EIF4G1 MKI67	4.20e-05	118	185	6	30979931
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	KIF26B TAS1R3 ZC3H13 BCORL1 CAMSAP3 PCARE ZBTB44 TDRD3 LMNA PKHD1 FMN2 IGSF9B KAZN ELP4	4.38e-05	736	185	14	29676528
Pubmed	A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.	NUMA1 CAMSAP3 LMNA MKI67 ZNF324 PRPH	5.80e-05	125	185	6	21654808
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	ANK3 BCAS3 ENTR1 CAMSAP3 TDRD3 SIPA1L1 CEP170B ELP4	6.41e-05	251	185	8	29778605
Pubmed	A conserved regulatory logic controls temporal identity in mouse neural progenitors.	EBF1 VSX1 MKI67	6.43e-05	15	185	3	25654255
Pubmed	Mash1 and Math3 are required for development of branchiomotor neurons and maintenance of neural progenitors.	MAP2 EBF1 MKI67	6.43e-05	15	185	3	15976074
Pubmed	Mechanisms and Consequences of Dopamine Depletion-Induced Attenuation of the Spinophilin/Neurofilament Medium Interaction.	SYNPO DLGAP3 KIAA1217 ERC2 DNM1 AGAP2	7.53e-05	131	185	6	28634551
Pubmed	A comprehensive resource of interacting protein regions for refining human transcription factor networks.	ATF7 SCHIP1 ANK3 MAP2 ZC3H13 ERC2 TP53BP1	7.78e-05	191	185	7	20195357
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	BICD2 ENTR1 BCORL1 ZC3H18 RUFY1 TDRD3 BRF1 KIAA1217 ERC2 ROCK1 CEP170B TP53BP1	8.05e-05	588	185	12	38580884
Pubmed	Utility of Peripherin Versus MAP-2 and Calretinin in the Evaluation of Hirschsprung Disease.	MAP2 PRPH	8.41e-05	3	185	2	26469323
Pubmed	Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer.	MAST2 MAST1	8.41e-05	3	185	2	22101766
Pubmed	Progerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria.	TERT LMNA	8.41e-05	3	185	2	26312502
Pubmed	C-terminal splice variants of P/Q-type Ca2+ channel CaV2.1 α1 subunits are differentially regulated by Rab3-interacting molecule proteins.	CACNA1A RIMS2	8.41e-05	3	185	2	28377503
Pubmed	ROCK-mediated selective activation of PERK signalling causes fibroblast reprogramming and tumour progression through a CRELD2-dependent mechanism.	ROCK1 EIF2AK3	8.41e-05	3	185	2	32451439
Pubmed	Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population.	TERT PHLDB1	8.41e-05	3	185	2	21350045
Pubmed	Multiple phases of expression and regulation of mouse Hoxc8 during early embryogenesis.	MAP2 PRPH	8.41e-05	3	185	2	9723177
Pubmed	[Expression and significance of hTERT, c-myc and Ki-67 in hepatocellular carcinoma].	TERT MKI67	8.41e-05	3	185	2	19351506
Pubmed	Nuclear IGF1R interacts with NuMA and regulates 53BP1‑dependent DNA double‑strand break repair in colorectal cancer.	NUMA1 TP53BP1	8.41e-05	3	185	2	34165167
Pubmed	The Chromatin-Associated Phf12 Protein Maintains Nucleolar Integrity and Prevents Premature Cellular Senescence.	PHF12 MKI67	8.41e-05	3	185	2	27956701
Pubmed	Kif26b controls endothelial cell polarity through the Dishevelled/Daam1-dependent planar cell polarity-signaling pathway.	KIF26B DVL3	8.41e-05	3	185	2	26792835
Interaction	YWHAH interactions	DAB2IP SLAIN2 MAP2 KIF26B BCAS3 ARHGEF5 CAMK2G ZC3H13 MEX3D SPATA18 CAMSAP3 MAST2 HDAC7 GLCCI1 PHLDB1 MAP7D1 MAST4 CSNK1D STARD9 KIAA1217 SIPA1L1 MARK4 EIF4G1 MAST1 FMN2 NHS SSH2 RIMS2 SRRM2 HECTD1 USP6NL CEP170B WNK2 MAST3 TNS3 MAP3K2	1.19e-11	1102	181	36	int:YWHAH
Interaction	YWHAG interactions	DAB2IP SLAIN2 MAP2 KIF26B BCAS3 ARHGEF5 CAMK2G ZC3H13 SPATA18 CAMSAP3 SYNPO MAST2 HDAC7 GLCCI1 PHLDB1 MAP7D1 MAST4 LMNA STARD9 SIPA1L1 MARK4 EIF4G1 ANKRD34A FMN2 NHS SSH2 SRRM2 LNX1 HECTD1 PCDH7 USP6NL CEP170B MAST3 TNS3 MAP3K2	1.47e-09	1248	181	35	int:YWHAG
Interaction	YWHAZ interactions	DAB2IP MAP2 KIF26B ARHGEF5 CAMK2G SPATA18 CAMSAP3 SYNPO ZC3H18 MAST2 RUFY1 TERT HDAC7 GLCCI1 PHLDB1 MAP7D1 MAST4 LMNA CSNK1D STARD9 SIPA1L1 MARK4 ANKRD34A MAST1 DLAT NHS SSH2 LNX1 HECTD1 PCDH7 USP6NL CEP170B WNK2 TP53BP1 MAST3 MAP3K2	1.70e-09	1319	181	36	int:YWHAZ
Interaction	YWHAE interactions	DAB2IP KIF26B ARHGEF5 CAMK2G RBMY1A1 SPATA18 CAMSAP3 ZC3H18 MAST2 RUFY1 HDAC7 GLCCI1 DLGAP3 PHLDB1 MAP7D1 MAST4 SIPA1L1 MARK4 ANKRD34A MAST1 NHS ERC2 ROCK1 LTBP1 SSH2 RIMS2 SRRM2 HECTD1 PCDH7 USP6NL CEP170B WNK2 MAST3 STOML2 MAP3K2	1.74e-09	1256	181	35	int:YWHAE
Interaction	YWHAB interactions	DAB2IP SLAIN2 MAP2 KIF26B ARHGEF5 CAMK2G SPATA18 CAMSAP3 MAST2 HDAC7 GLCCI1 PHLDB1 MAP7D1 MAST4 STARD9 SIPA1L1 MARK4 EIF4G1 ANKRD34A MAST1 NHS SSH2 SRRM2 LNX1 HECTD1 USP6NL CEP170B MAST3 TNS3 MAP3K2 AGAP2	1.97e-09	1014	181	31	int:YWHAB
Interaction	SFN interactions	SETD1A MAP2 KIF26B ARHGEF5 CAMSAP3 GRB7 ZC3H18 MAST2 HDAC7 PHLDB1 MAP7D1 MAST4 LMNA SIPA1L1 EIF4G1 FMN2 NHS SSH2 SRRM2 HECTD1 PCDH7 USP6NL CEP170B TNS3 MAP3K2	3.27e-09	692	181	25	int:SFN
Interaction	YWHAQ interactions	DAB2IP MAP2 KIF26B ARHGEF5 ZC3H13 SPATA18 NUMA1 CAMSAP3 MAST2 RUFY1 TERT HDAC7 GLCCI1 PHLDB1 MAP7D1 MAST4 LMNA PABPN1 STARD9 SIPA1L1 EIF4G1 NHS SSH2 LNX1 HECTD1 PCDH7 USP6NL CEP170B TNS3 MAP3K2	6.99e-08	1118	181	30	int:YWHAQ
Interaction	KALRN interactions	DAB2IP CACNA1A CAMK2G CAMSAP3 SYNPO CIT SIPA1L1 LNX1 AGAP2	2.06e-07	96	181	9	int:KALRN
Interaction	SHANK3 interactions	SHANK1 ANK3 MAP2 PHF12 CAMK2G NUMA1 FRS3 DVL3 SYNPO CIT DLGAP3 PHLDB1 CSNK1D ERC2 DNM1 STOML2 AGAP2	2.58e-06	496	181	17	int:SHANK3
Interaction	MAST4 interactions	BICD2 MAST2 MAST4 MAST1 MAST3	3.12e-06	26	181	5	int:MAST4
Interaction	KCTD13 interactions	SHANK1 CACNA1A ANK3 MAP2 PRR36 BCAS3 CAMK2G CAMSAP3 SYNPO CIT JMY GAS2L1 DLGAP3 PHLDB1 MAP7D1 LMNA CSNK1D KIAA1217 SIPA1L1 EIF4G1 MAST1 DLAT ERC2 SSH2 DNM1 LNX1 CEP170B WNK2 STOML2 AGAP2	6.89e-06	1394	181	30	int:KCTD13
Interaction	TNIK interactions	SHANK1 BICD2 CACNA1A ANK3 CAMK2G CIT TDRD3 KIAA1217 SIPA1L1 ERC2 DNM1 CEP170B TP53BP1 AGAP2	9.38e-06	381	181	14	int:TNIK
Interaction	MAPRE1 interactions	BICD2 SLAIN2 MAP2 CAMK2G NUMA1 CAMSAP3 SYNPO GAS2L1 TDRD3 MAP7D1 MAST4 MAVS KIAA1217 EIF4G1 SRRM2 CEP170B	1.70e-05	514	181	16	int:MAPRE1
Interaction	AGAP2 interactions	DAB2IP SHANK1 ANK3 CAMK2G DLGAP3 DNM1 RIMS2 PCDH7 CEP170B AGAP2	2.09e-05	210	181	10	int:AGAP2
Interaction	DLGAP1 interactions	DAB2IP SHANK1 CAMK2G SYNPO CIT DLGAP3 KIAA1217 DNM1 AGAP2	3.73e-05	180	181	9	int:DLGAP1
Interaction	SLC6A4 interactions	DAB2IP CAMSAP3 SYNPO DLGAP3 CSNK1D STARD9 SIPA1L1 MARK4 MYO1F MAST1 CEP170B STOML2 AGAP2 PRPH	4.27e-05	437	181	14	int:SLC6A4
Interaction	MAPRE3 interactions	SLAIN2 MAP2 CAMSAP3 KLHDC7B GAS2L1 TDRD3 MAP7D1 MAST4 KIAA1217 CEP170B	4.55e-05	230	181	10	int:MAPRE3
Interaction	TRIM36 interactions	SLAIN2 MAP2 CAMSAP3 GRB7 TDRD3 MAP7D1 MAST4 CEP170B	4.83e-05	144	181	8	int:TRIM36
Interaction	TOP3B interactions	DAB2IP SETD1A BCAS3 PHF12 MEX3D THAP8 AMBRA1 LRRK1 PLXND1 MAST2 CIT HDAC7 GAS2L1 HEYL TDRD3 PHLDB1 PABPN1 MARK4 EIF4G1 CTDP1 TXNRD3 ANKRD34A DLAT HECTD1 ADAMTSL4 PLK3 CEP170B WNK2 TP53BP1	4.99e-05	1470	181	29	int:TOP3B
Interaction	PNMA2 interactions	CAMK2G CAMSAP3 ZC3H3 ZNF785 ZNF783 MAP7D1 MARK4 MAST1 CEP170B MAST3	9.42e-05	251	181	10	int:PNMA2
Interaction	SYNGAP1 interactions	DAB2IP SHANK1 NYAP2 MAP2 DLGAP3 SIPA1L1 DNM1 LNX1 ADGRL3 TP53BP1 AGAP2	1.09e-04	307	181	11	int:SYNGAP1
Interaction	RACGAP1 interactions	GRB7 CIT KLF16 LMNA BAZ2A EIF4G1 MKI67 SP6 HECTD1	1.14e-04	208	181	9	int:RACGAP1
Interaction	RBMY1J interactions	RBMY1A1 RBMY1E RBMY1F LNX1	1.25e-04	29	181	4	int:RBMY1J
Cytoband	Yq11.223	RBMY1A1 RBMY1D RBMY1B RBMY1E RBMY1F	4.13e-05	93	187	5	Yq11.223
Cytoband	Ensembl 112 genes in cytogenetic band chr15q15	CCDC9B CDAN1 STARD9 PAK6-AS1 TP53BP1	3.56e-04	147	187	5	chr15q15
GeneFamily	PDZ domain containing	SHANK1 DVL3 MAST2 TAMALIN MAST4 SIPA1L1 MAST1 RIMS2 LNX1 MAST3	3.88e-08	152	113	10	1220
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	GRB7 ARHGAP22 PHLDB1 PLEKHG6 ROCK1 PLEKHH2 DNM1 AGAP2	4.56e-05	206	113	8	682
GeneFamily	RNA binding motif containing	SETD1A RBMY1A1 RBMY1C RBMY1D RBMY1B RBMY1E PABPN1 RBMY1F	5.77e-05	213	113	8	725
GeneFamily	Zinc fingers CCCH-type	ZC3H13 ZC3H18 ZC3H3	1.34e-03	35	113	3	73
Coexpression	CHEN_ETV5_TARGETS_TESTIS	RBMY1A1 RBMY1D RBMY1B RBMY1E MKI67	3.27e-06	33	184	5	MM701
Coexpression	GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_DN	ADM GAS2L1 MAP7D1 METTL24 DLAT IGSF9B EIF2AK3 PLK3 CEP170B	1.27e-05	200	184	9	M6417
Coexpression	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	KIF26B RBMY1A1 SPATA18 RBMY1D RBMY1B RBMY1E AMBRA1 FTMT LRRK1 TBC1D3B ARHGAP22 PLCH2 ARMC5 RBMY1F MTHFD2L KAZN OTULINL WNK2 TRMT12	1.35e-05	873	184	19	M16009
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	MAP2 PRR36 PHF12 WDR81 RTN2 FSD1L KIAA1217 PLK3 WNK2	3.57e-05	196	174	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K2
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#5_top-relative-expression-ranked_500	SCHIP1 SYNM ADM FNDC1 LMNA ADAMTSL4	4.07e-05	77	174	6	gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_500_k5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000	SHANK1 CACNA1A ROBO4 PRR36 KIF26B TAS1R3 ARHGEF5 SYNPO HEYL FNDC1 MAST1 FGF2 FMN2 ERC2 CACNA1G LTBP1 DNM1 PLK3 CEP170B ADGRL3 WNK2	4.55e-05	967	174	21	Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3	SHANK1 CACNA1A MAP2 PRR36 TAS1R3 WDR81 CIT TAMALIN RTN2 GLCCI1 SSC5D FSD1L USP51 MAST1 FMN2 ERC2 RIMS2 PLK3 PIGO WNK2	4.56e-05	893	174	20	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000	CACNA1A ROBO4 MAP2 PRR36 ARHGEF5 CAMSAP3 WDR81 CIT RTN2 FNDC1 FSD1L USP51 MAST1 FMN2 NHS ERC2 LTBP1 RIMS2 PLK3 PIGO WNK2	6.00e-05	986	174	21	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5	SHANK1 CACNA1A MAP2 PRR36 TAS1R3 TAMALIN RTN2 GLCCI1 SSC5D USP51 STARD9 MAST1 FMN2 ERC2 RIMS2 PLK3 WNK2	1.13e-04	732	174	17	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_OlfacPit_2500_K1	PRR36 CAMSAP3 GRB7 DENND1C LRRK1 HUNK PLCH2 KIAA1217 SP6 LNX1 PLK3 CEP170B	1.25e-04	402	174	12	facebase_RNAseq_e10.5_OlfacPit_2500_K1
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2	SHANK1 CACNA1A MAP2 KIF26B ARHGEF5 MTSS1 DVL3 SYNPO PLXND1 HDAC7 TAMALIN CHST8 TDRD3 LMNA ARMC5 FGF2 CACNA1G TMEM151A PLEKHH2 DNM1 PRDM15 PCDH7 ADGRL3	1.42e-04	1208	174	23	facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	MAP2 PRR36 WDR81 RTN2 FSD1L KIAA1217 MAST1 PLK3 USP6NL WNK2 TP53BP1	1.54e-04	350	174	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	CACNA1A MAP2 PRR36 SYNM KIF26B CAMSAP3 SYNPO CIT RTN2 FSD1L USP51 MAST1 FGF2 FMN2 NHS ERC2 ROCK1 RIMS2 PLK3 WNK2	1.68e-04	983	174	20	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000	SHANK1 ANK3 MAP2 PRR36 KIF26B CAMSAP3 GRB7 SYNPO RTN2 FNDC1 PLCH2 MAST1 FGF2 FMN2 NHS CACNA1G RIMS2 PLK3 CEP170B ADGRL3	1.70e-04	984	174	20	Facebase_RNAseq_e10.5_Olfactory Pit_1000
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_500	SETD1A ZC3H13 ZBTB44 MAST4 EIF4G1	1.94e-04	65	174	5	gudmap_developingGonad_P2_ovary_500_k2
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#4	SHANK1 CACNA1A PRR36 TAS1R3 MAST1 FMN2 ERC2 PLK3 WNK2	2.08e-04	247	174	9	Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1	SHANK1 MAP2 PRR36 WDR81 RTN2 SSC5D SIPA1L1 PLK3 USP6NL TP53BP1	2.25e-04	306	174	10	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#3	MAP2 PRR36 RTN2 FSD1L PLK3 WNK2	2.66e-04	108	174	6	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K3
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Intermediate\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	DAB2IP BICD2 STK35 JMY ZNF783 PLEKHG6 PLCH2 CTDP1 FMN2 LTBP1 AGAP2	6.23e-10	200	180	11	a3fcd901cb281920f1bafdfd676399a6dc37355e
ToppCell	RA-07._Pericyte\|RA / Chamber and Cluster_Paper	CACNA1A UPB1 MAP2 EBF1 PLXND1 HEYL DLGAP3 NHS ADGRL3	5.59e-08	181	180	9	8dfb42d096db6c2df9b41303a7199d134d4bff07
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYNM EBF1 HEYL FNDC1 NHS LTBP1 IGSF9B PCDH7 ADGRL3	1.31e-07	200	180	9	a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCell	E18.5-samps-Mesenchymal-Pericyte-pericyte_D\|E18.5-samps / Age Group, Lineage, Cell class and subclass	MAP2 SYNPO EBF1 HEYL FNDC1 NHS LTBP1 PCDH7	1.73e-07	149	180	8	dcf68eb25733b5db2893728fe4dca5c7267eb58c
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	KIF26B KIF12 HUNK PKHD1 FMN2 NHS KAZN DNM1	6.71e-07	178	180	8	544379f5a6145429762258d426b876bb36c112f5
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B CNTNAP3 ADM PLCH2 KIAA1217 NHS INPP5J	7.00e-07	179	180	8	d1365d48d1b017a7917f4f63a82ac4720c3d87df
ToppCell	Control-Endothelial_cells-Capillary_endothelial_cells\|Control / group, cell type (main and fine annotations)	ROBO4 HLA-E LINC00472 TAMALIN PHLDB1 KIAA1217 LNX1 ADGRL3	7.30e-07	180	180	8	b043f9ffb9a4cd427a15bebb86a711c7b08866e8
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	SYNM EBF1 HEYL NHS LTBP1 IGSF9B PCDH7 ADGRL3	7.30e-07	180	180	8	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	RA-07._Pericyte\|World / Chamber and Cluster_Paper	CACNA1A UPB1 MAP2 EBF1 PLXND1 HEYL DLGAP3 NHS	7.93e-07	182	180	8	2075efeae633550fb2eb026d0dfd741c8252482e
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	DAB2IP CCDC9B MAP2 SYNPO CIT FNDC1 OTULINL PLEKHH2	8.27e-07	183	180	8	6821dca076318115d360ff426eb1218cfe104063
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	KIF26B EBF1 HEYL FBXL22 NHS LTBP1 PCDH7 ADGRL3	9.73e-07	187	180	8	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CNTNAP3B ROBO4 HLA-E LINC00472 TAMALIN KIAA1217 SP6 ADGRL3	9.73e-07	187	180	8	97b2463fb37e7196dd2f92553acf8e7bc3ec40dd
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Adult / Lineage, Cell type, age group and donor	ROBO4 HLA-E TAMALIN PHLDB1 KIAA1217 SP6 LNX1 ADGRL3	1.01e-06	188	180	8	e5cad03f4a64147fe8174e7f614cf45233ffb9b7
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LINC00472 HUNK GLCCI1 PKHD1 KAZN PLEKHH2 ADGRL3 TNS3	1.01e-06	188	180	8	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	KIF26B HEYL SSC5D FBXL22 DLEU7 NHS LTBP1 OTULINL	1.01e-06	188	180	8	3004e961d214919e08c7cd5f10c3de5cf85b35a3
ToppCell	3'-Adult-Distal_Rectal-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1A MAP2 SYNM EBF1 CHST8 HEYL STARD9 LTBP1	1.05e-06	189	180	8	d69b7a01dd4d6ad043bb6210e9ab34b49578389c
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B CNTNAP3 PCARE HUNK KIAA1217 NHS INPP5J	1.05e-06	189	180	8	99a13b1b669b0cd36e3096632351d9ade25d1173
ToppCell	3'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1A MAP2 SYNM EBF1 CHST8 HEYL STARD9 LTBP1	1.05e-06	189	180	8	2b5f1b4f173a224342ea4f10b193ee33b7662699
ToppCell	3'-Adult-Distal_Rectal-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1A MAP2 SYNM EBF1 CHST8 HEYL STARD9 LTBP1	1.05e-06	189	180	8	43e131458d8a4b120f7a5fb3d0c5650abded15f6
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B MTSS1 CNTNAP3 HUNK KIAA1217 NHS INPP5J	1.10e-06	190	180	8	26843ec1d19ac85a50990705353b802745d33e4d
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B CNTNAP3 PCARE HUNK KIAA1217 NHS INPP5J	1.10e-06	190	180	8	39ab890104b4264c68a968f920f4ccd84f0bc681
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CNTNAP3B ROBO4 HLA-E PLXND1 TAMALIN PHLDB1 KIAA1217 ADGRL3	1.14e-06	191	180	8	1de0bdfd13bd930691564c2673f2e66393bc0255
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B CNTNAP3 HUNK KIAA1217 NHS KAZN INPP5J	1.23e-06	193	180	8	4979862c0c16e6b4baa4c79894f1d237c861f5a5
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYNM OTOP3 VSX1 STARD9 LTBP1 IGSF9B PCDH7 ADGRL3	1.44e-06	197	180	8	ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B ROBO4 MAP2 HLA-E SYNPO EBF1 PLXND1 TAMALIN	1.49e-06	198	180	8	b027a141ab531d0f5d6a26811a53427e7b0771dd
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CACNA1A MAP2 KIF26B KIAA1217 KAZN PLEKHH2 RIMS2 PCDH7	1.61e-06	200	180	8	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CACNA1A MAP2 KIF26B KIAA1217 KAZN PLEKHH2 RIMS2 PCDH7	1.61e-06	200	180	8	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B KIF26B CNTNAP3 PCARE HUNK KIAA1217 NHS INPP5J	1.61e-06	200	180	8	c65e6336725856c4b5f6aeba1cf86a23ec815d34
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CACNA1A MAP2 KIF26B KIAA1217 KAZN PLEKHH2 RIMS2 PCDH7	1.61e-06	200	180	8	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CACNA1A MAP2 KIF26B KIAA1217 KAZN PLEKHH2 RIMS2 PCDH7	1.61e-06	200	180	8	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CACNA1A MAP2 KIF26B KIAA1217 KAZN PLEKHH2 RIMS2 PCDH7	1.61e-06	200	180	8	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B KIF26B CNTNAP3 PCARE HUNK KIAA1217 NHS INPP5J	1.61e-06	200	180	8	117a25b3b9cdbc2e198381350a8362bee25e82e7
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CACNA1A MAP2 KIF26B KIAA1217 KAZN PLEKHH2 RIMS2 PCDH7	1.61e-06	200	180	8	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B KIF26B CNTNAP3 PCARE HUNK KIAA1217 NHS INPP5J	1.61e-06	200	180	8	d459e51507bf26865e6e7e04411379ec82a3edf8
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CCNO HUNK KIAA1217 NHS CDT1 PCDH7 WNK2	4.24e-06	161	180	7	2d63b279d9a5132e1c09b03930bf9039036d24a2
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A STK35 FNDC1 C3AR1 CACNA1G OTULINL DNM1	5.39e-06	167	180	7	f5bffa77061baec0ba87bd688a047595f32534db
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SYNM EBF1 NHS LTBP1 IGSF9B PCDH7 ADGRL3	6.79e-06	173	180	7	cb6389536195443633adb06e5f1b7483530773d1
ToppCell	Adult-Epithelial-lung_goblet_cell-D231\|Adult / Lineage, Cell type, age group and donor	CCNO HUNK KIAA1217 NHS LNX1 PCDH7 WNK2	7.06e-06	174	180	7	7d2f802f493f19a068e097b2909a9000e2160266
ToppCell	facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP2 CHST8 DLGAP3 FBXL22 MKI67 RIMS2 WNK2	7.33e-06	175	180	7	d8e385320f554d974538b7cdc4f8e4767f1455f2
ToppCell	facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP2 CHST8 DLGAP3 FBXL22 MKI67 RIMS2 WNK2	7.33e-06	175	180	7	cf15465855602ba135752c18755e3e058dbd42ec
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	ZC3H13 BCORL1 ISM2 HEYL FNDC1 LTBP1 TNS3	8.18e-06	178	180	7	edc76b8f15056ec1c9a1c61a048b6331a92592d6
ToppCell	Adult-Epithelial-lung_goblet_cell\|Adult / Lineage, Cell type, age group and donor	CCNO HUNK KIAA1217 NHS LNX1 PCDH7 WNK2	8.49e-06	179	180	7	1fc1f252ca943a2f649d1e627f56acbf15f8e058
ToppCell	COVID-19-kidney-vSMC/Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MAP2 SYNM EBF1 HEYL NHS LTBP1 ADGRL3	8.49e-06	179	180	7	111b1084f73306bdeffaaf240e7dbb4f5bf33de1
ToppCell	droplet-Fat-Bat-18m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BICD2 MAP2 FRS3 SYNPO CHST8 LNX1 USP6NL	8.49e-06	179	180	7	e6224864eb76a2e9c1fc0c61513d9e936bb5c72c
ToppCell	droplet-Fat-Bat-18m-Endothelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BICD2 MAP2 FRS3 SYNPO CHST8 LNX1 USP6NL	8.49e-06	179	180	7	9863ab3ceb160a4b1d9790033a4ac48845863d65
ToppCell	droplet-Fat-Bat-18m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BICD2 MAP2 FRS3 SYNPO CHST8 LNX1 USP6NL	8.49e-06	179	180	7	dfe110add7228cd834b35916cbcc849769a01bb9
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B CNTNAP3 HUNK KIAA1217 NHS INPP5J	9.46e-06	182	180	7	a3c5c0eff527c8d3848acda14af8f9e99c69b0de
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	CACNA1A CAMK2G EBF1 NHS ROCK1 PCDH7 ADGRL3	9.80e-06	183	180	7	818fd886e0188091310825f9145fa53328f2c979
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CNTNAP3 PCARE HUNK KIAA1217 NHS INPP5J	9.80e-06	183	180	7	d2074b13b4831ec18c81273d9a1ff673c3f6a16d
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B CNTNAP3 HUNK KIAA1217 NHS INPP5J	9.80e-06	183	180	7	04d3cc76038b8192c915f1c08c3e26f2ad3b3779
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	KIF26B SSC5D FBXL22 DLEU7 NHS LTBP1 OTULINL	9.80e-06	183	180	7	e84539978ab4de42e19186aed00f24bb50cbc21f
ToppCell	Substantia_nigra-Neuronal-Inhibitory\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	NYAP2 KIF26B CAMSAP3 ANKRD34A MAST1 DLEU7 DNM1	1.09e-05	186	180	7	9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B ANK3 KIF26B MAST4 PKHD1 NHS DNM1	1.09e-05	186	180	7	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B CNTNAP3 HUNK KIAA1217 NHS INPP5J	1.13e-05	187	180	7	d413fb4b1531b297af5012a392b88128510c2de8
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	CCNO HUNK MAST4 KIAA1217 NHS LNX1 WNK2	1.13e-05	187	180	7	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAP2 EBF1 HEYL STARD9 LTBP1 ADGRL3 AGAP2	1.13e-05	187	180	7	48bfdb3504c3fefe5db3abac4b790c369680ab4e
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAP2 EBF1 HEYL STARD9 LTBP1 ADGRL3 AGAP2	1.13e-05	187	180	7	958402fcc78f4c7a7d13d659d776f3817137975f
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EBF1 HDAC7 SSC5D FNDC1 FSD1L PCDH7 ADAMTSL4	1.17e-05	188	180	7	aa516273cdde53c8c0295f06830972388f890c97
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	NYAP2 PRR36 KIF26B CAMSAP3 MAST1 DLEU7 ERC2	1.17e-05	188	180	7	b73e8a40393c3f656e2fcfe395a761b1f985c254
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B CNTNAP3 HUNK KIAA1217 NHS INPP5J	1.17e-05	188	180	7	8de5a07301f9b5984680c873e5a92395b5ed3dd3
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_3\|Classical_Monocyte / Disease condition and Cell class	WDR81 TAMALIN TDRD3 LMNA MARK4 C3AR1 ADAMTSL4	1.21e-05	189	180	7	8b6f92ccfffc743c07201bc971b3dc1a6fa14ccc
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B CNTNAP3 HUNK KIAA1217 NHS INPP5J	1.25e-05	190	180	7	d19bc44310c53726e2f5f6a2bd377bbbf1d1983f
ToppCell	Adult-Epithelial-club_cell\|Adult / Lineage, Cell type, age group and donor	CCNO HUNK MAST4 KIAA1217 NHS LNX1 WNK2	1.25e-05	190	180	7	756bff697d30aec56c0ebfca94295f084a15bf37
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ROBO4 LINC00472 TAMALIN PHLDB1 STARD9 KIAA1217 ADGRL3	1.25e-05	190	180	7	0e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B CNTNAP3 HUNK KIAA1217 NHS INPP5J	1.25e-05	190	180	7	3f22c118d552345f731d4d49f0bcb5765d93de3b
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B CNTNAP3 HUNK KIAA1217 NHS INPP5J	1.25e-05	190	180	7	305fbef734c350cfbf786ca7ff6e07093aab56ea
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	EBF1 HUNK HEYL SP6 KAZN OTULINL ADGRL3	1.25e-05	190	180	7	979b1476fd2692fde977ce56257315fcfc8a01d5
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B CNTNAP3 HUNK KIAA1217 NHS INPP5J	1.25e-05	190	180	7	8c9c230a509afaeee50644153974a5642b01a2b8
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B CNTNAP3 HUNK KIAA1217 NHS INPP5J	1.25e-05	190	180	7	0acf1d5da68db449d8c9e70519a236ce825f9d11
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B CNTNAP3 HUNK KIAA1217 NHS INPP5J	1.25e-05	190	180	7	e58e4b6fbeb4368f738adac67ec10879c0966f0f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B ROBO4 HLA-E EBF1 PLXND1 STARD9 MARK4	1.29e-05	191	180	7	f663131a4810584c5854bd64ee7991a237b7707f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LINC00472 HUNK PKHD1 KAZN PLEKHH2 ADGRL3 TNS3	1.29e-05	191	180	7	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ROBO4 LINC00472 TAMALIN PHLDB1 STARD9 KIAA1217 ADGRL3	1.29e-05	191	180	7	f229abf69a1217194f74b0502486907e07dba989
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PKHD1 NHS ERC2 KAZN PLEKHH2 RIMS2 LNX1	1.29e-05	191	180	7	9032aa974aa1b7b1095b8d1b58dcb087358a5001
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PKHD1 NHS ERC2 KAZN PLEKHH2 RIMS2 LNX1	1.29e-05	191	180	7	5717809a1476c20f65bce722c5a57cff92ee0d7a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYNM EBF1 HEYL LTBP1 IGSF9B ADGRL3 WNK2	1.34e-05	192	180	7	bfab13793e54de2550ee171397f7ece0625cdb4a
ToppCell	Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|World / Lineage, Cell type, age group and donor	ROBO4 HLA-E LINC00472 TAMALIN PHLDB1 KIAA1217 ADGRL3	1.34e-05	192	180	7	1e156bab5ecf64627890d2de9b27603d9a01f28d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYNM EBF1 HEYL LTBP1 IGSF9B ADGRL3 WNK2	1.34e-05	192	180	7	b54b0d5b88139905521c8d5d58332e89c08d589c
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	EBF1 HUNK HEYL SP6 KAZN OTULINL ADGRL3	1.34e-05	192	180	7	063e119c4b58957643908f667e6cfd6f7517fd03
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B MTSS1 CNTNAP3 HUNK NHS KAZN	1.34e-05	192	180	7	67d6230e32d446dcb12047fae2c3f1faa80dd720
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B CNTNAP3 HUNK KIAA1217 NHS INPP5J	1.34e-05	192	180	7	0003d7ef9a8e521e70ac33c63aad843d9b6215c2
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 BCAS3 MAST4 SIPA1L1 PKHD1 NHS SSH2	1.34e-05	192	180	7	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B CNTNAP3 HUNK KIAA1217 NHS INPP5J	1.38e-05	193	180	7	53bcd50892c379b2a571751f6eb1062436339fe7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ROBO4 MAP2 HLA-E EBF1 PLXND1 TAMALIN FGF2	1.38e-05	193	180	7	6a623acd1adad9a78eddc32ffedb16352ad3fdfa
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B CNTNAP3 HUNK KIAA1217 NHS INPP5J	1.38e-05	193	180	7	c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B CNTNAP3 HUNK KIAA1217 NHS INPP5J	1.38e-05	193	180	7	5581a5ebcd21a2a8062ccfb917f088ec67a10a9c
ToppCell	droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 MAP2 ADM HEYL PLEKHH2 PCDH7 ADAMTSL4	1.43e-05	194	180	7	415801a3dfacf05f2b603fb424df3d045190a812
ToppCell	nucseq-Mesenchymal-Myocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SYNM KIF26B EBF1 HEYL FNDC1 LTBP1 PCDH7	1.43e-05	194	180	7	2d66091097e106c7bee22e5281f50724700bdf8d
ToppCell	droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 MAP2 ADM HEYL PLEKHH2 PCDH7 ADAMTSL4	1.43e-05	194	180	7	256cb33ec90328f2704921fb0fe0fd9812e138b0
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B KIF26B MTSS1 CNTNAP3 HUNK KIAA1217 NHS	1.43e-05	194	180	7	e5990880961d2469759ce4b3b20ae93ace3ebd1f
ToppCell	COVID-19-kidney-Glomerular_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CNTNAP3B ROBO4 MTSS1 HLA-E TAMALIN ADM KIAA1217	1.43e-05	194	180	7	660535b492445063d965095a50e1e299ce04c50a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MTSS1 LRRK1 PLXND1 ARHGAP22 MYO1F C3AR1 OTULINL	1.43e-05	194	180	7	1dce6d4b6ac41f80677e3e4c335a4f383bd76f85
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EBF1 HEYL LTBP1 IGSF9B PCDH7 ADGRL3 WNK2	1.43e-05	194	180	7	5c3b2b05d1e4f146551fe4c920263d8e6ca34de3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B ROBO4 HLA-E EBF1 PLXND1 STARD9 MARK4	1.43e-05	194	180	7	b490fffc94f005dff9a34ce34d80ca776e3a1387
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B ROBO4 HLA-E EBF1 PLXND1 TAMALIN MARK4	1.43e-05	194	180	7	ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EBF1 HEYL LTBP1 IGSF9B PCDH7 ADGRL3 WNK2	1.43e-05	194	180	7	ab9cad697f9209d2889bc02b43b502dfeb2ebfef
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP2 EBF1 HEYL FNDC1 LTBP1 PCDH7 ADGRL3	1.43e-05	194	180	7	ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCell	droplet-Liver-LIVER-NPC-1m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 MAP2 ADM HEYL PLEKHH2 PCDH7 ADAMTSL4	1.43e-05	194	180	7	7942bc83c1bdca687795b91aa232824d603f9b09
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	CNTNAP3B ROBO4 MAP2 HLA-E TAMALIN KIAA1217 LNX1	1.48e-05	195	180	7	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP3B ROBO4 HLA-E EBF1 PLXND1 TAMALIN STARD9	1.53e-05	196	180	7	8ad8efb631164b46f0c082572270188e5ead20bf
Drug	Econazole nitrate [24169-02-6]; Down 200; 9uM; MCF7; HT_HG-U133A	BICD2 GRB7 PLXND1 ZNF783 CEP68 PHLDB1 SLC12A9 LTBP1 SRRM2 CEP170B TP53BP1	4.16e-07	192	181	11	7427_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	MAP2 BCORL1 RTN2 ADM CEP68 PLEKHG6 MARK4 PLK3 MAST3 PRPH	1.87e-06	180	181	10	7407_UP
Drug	Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A	CAMK2G CCNO ZC3H3 RTN2 ADM PHLDB1 LMNA CTDP1 PCDH7 MAST3	4.01e-06	196	181	10	3536_DN
Drug	bromfenacoum	SLAIN2 CDV3 ANK3 MTSS1 CAMSAP3 ZC3H18 LMNA MAVS SLC12A9 DLAT ROCK1 KAZN RIMS2 MTX1 SRRM2 HECTD1 CEP170B INPP5J	4.13e-06	644	181	18	ctd:C013418
Drug	Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; MCF7; HT_HG-U133A	PRR36 CCNO GRB7 MAST2 ZNF783 TDRD3 FBXL18 SIPA1L1 MARK4 INPP5J	4.20e-06	197	181	10	5436_DN
Drug	Levopropoxyphene napsylate [5714-90-9]; Up 200; 7.4uM; PC3; HT_HG-U133A	SHANK1 CACNA1A UPB1 MTSS1 GRB7 CHST8 GAS2L1 HEYL PHLDB1 AGAP2	4.20e-06	197	181	10	5083_UP
Drug	oligoadenylate	ANK3 RBMY1A1 HLA-E RBMY1D RBMY1B RBMY1E TERT PABPN1 EIF2AK3	4.79e-06	157	181	9	CID000107918
Drug	Gentamicine sulfate [1405-41-0]; Down 200; 2.6uM; PC3; HT_HG-U133A	FRS3 AMBRA1 PLXND1 ZNF783 CHST8 SLC12A9 BAZ2A CDT1 KAZN PRPH	4.80e-06	200	181	10	5883_DN
Drug	Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; MCF7; HT_HG-U133A	BCORL1 CCNO ZC3H3 SLC12A9 MARK4 CTDP1 MKI67 CDT1 PIGO	1.88e-05	186	181	9	3518_DN
Drug	hydantoin-5-propionic acid	RBMY1A1 RBMY1D RBMY1B RBMY1E	2.08e-05	21	181	4	CID000000782
Drug	0317956-0000 [391210-11-0]; Down 200; 10uM; MCF7; HT_HG-U133A	PRR36 CAMK2G CCNO HDAC7 RIMS2 PCDH7 PLK3 INPP5J TNS3	2.32e-05	191	181	9	3855_DN
Drug	Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	CACNA1A BCORL1 NUMA1 AMBRA1 RTN2 MARK4 CTDP1 PIGO MAST3	2.51e-05	193	181	9	3262_UP
Drug	Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; PC3; HT_HG-U133A	BICD2 MEX3D AMBRA1 LRRK1 CHST8 ARHGAP22 TDRD3 PHLDB1 SRRM2	2.51e-05	193	181	9	1817_UP
Drug	Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A	SYNM CCNO MAST2 CEP68 PHLDB1 MARK4 DNM1 RIMS2 MAST3	2.62e-05	194	181	9	4411_DN
Drug	Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; PC3; HT_HG-U133A	CACNA1A MTSS1 DVL3 AMBRA1 PLXND1 ZNF783 CHST8 MAST4 BAZ2A	2.84e-05	196	181	9	4594_DN
Drug	Sulfamethoxypyridazine [80-35-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A	SETD1A CAMK2G NUMA1 GRB7 RTN2 BRF1 LMNA MARK4 MAST3	2.84e-05	196	181	9	3409_UP
Drug	Solasodine [126-17-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	PRR36 CHST8 BRF1 MAST4 BAZ2A MARK4 MYO1F CTDP1 RIMS2	2.84e-05	196	181	9	3830_DN
Drug	genistein; Up 200; 10uM; MCF7; HT_HG-U133A	PRR36 DVL3 AMBRA1 ZNF783 ZNF324 FGF2 KAZN SRRM2 PLK3	2.84e-05	196	181	9	5232_UP
Drug	Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; PC3; HT_HG-U133A	MAP2 NUMA1 LRRK1 TDRD3 PLEKHG6 BAZ2A KAZN RIMS2 PIGO	2.96e-05	197	181	9	3801_DN
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	MAP2 PRR36 PLEKHG6 MYO1F FGF2 OTULINL DNM1 RIMS2 INPP5J	2.96e-05	197	181	9	3886_DN
Drug	Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A	CCNO PHLDB1 BRF1 MAST4 FBXL18 PABPN1 SIPA1L1 CTDP1 PIGO	2.96e-05	197	181	9	5453_DN
Drug	LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A	CAMK2G CCNO CHST8 TDRD3 MAST4 MYO1F MTHFD2L USP6NL CEP170B	2.96e-05	197	181	9	5236_DN
Drug	troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A	SETD1A PHLDB1 BRF1 FBXL18 SLC12A9 BAZ2A MARK4 PLK3 INPP5J	2.96e-05	197	181	9	5592_DN
Drug	Alfadolone acetate [23930-37-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A	PRR36 CAMK2G DVL3 ZNF783 BRF1 BAZ2A CTDP1 PLK3 PIGO	2.96e-05	197	181	9	6506_UP
Drug	AZFd	RBMY1A1 RBMY1D RBMY1B RBMY1E	3.04e-05	23	181	4	CID000196489
Drug	Oxymetazoline hydrochloride [2315-02-8]; Up 200; 13.4uM; HL60; HG-U133A	GRB7 ZNF783 TDRD3 BRF1 FBXL18 SLC12A9 BAZ2A ADAMTSL4 CEP170B	3.07e-05	198	181	9	1431_UP
Drug	Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	FRS3 ZNF783 CHST8 GAS2L1 MAST4 MYO1F CTDP1 SRRM2 MAST3	3.07e-05	198	181	9	5786_DN
Drug	Minoxidil [38304-91-5]; Down 200; 19.2uM; MCF7; HT_HG-U133A	ANK3 PRR36 CEP68 MAP7D1 BRF1 FBXL18 BAZ2A MARK4 CEP170B	3.07e-05	198	181	9	4800_DN
Drug	Norfloxacin [70458-96-7]; Up 200; 12.6uM; PC3; HT_HG-U133A	ROBO4 BCAS3 LRRK1 CHST8 ARHGAP22 TDRD3 LMNA MYO1F PLK3	3.07e-05	198	181	9	2090_UP
Drug	Flecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	PRR36 ZC3H3 TDRD3 BRF1 SIPA1L1 MARK4 DNM1 RIMS2 PCDH7	3.07e-05	198	181	9	3843_DN
Drug	ICI 182,780; Down 200; 0.01uM; PC3; HT_HG-U133A	CEP68 TDRD3 PLEKHG6 MARK4 CTDP1 ZNF324 KAZN PIGO MAST3	3.07e-05	198	181	9	1238_DN
Drug	Scopoletin [92-61-5]; Down 200; 20.8uM; HL60; HT_HG-U133A	PLXND1 MAST2 RTN2 MARK4 ZNF324 KAZN OTULINL PLK3 MAP3K2	3.07e-05	198	181	9	3131_DN
Drug	Harpagoside [19210-12-9]; Up 200; 8uM; MCF7; HT_HG-U133A	CAMK2G NUMA1 CCNO ZNF783 BRF1 BAZ2A OTULINL RIMS2 SRRM2	3.07e-05	198	181	9	4981_UP
Drug	Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; MCF7; HT_HG-U133A	CAMK2G BCORL1 PHLDB1 SLC12A9 BAZ2A MYO1F MTHFD2L PIGO CEP170B	3.20e-05	199	181	9	3543_DN
Drug	beta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; MCF7; HT_HG-U133A	DVL3 ADM MAST4 MARK4 MYO1F KAZN DNM1 PCDH7 INPP5J	3.20e-05	199	181	9	2819_DN
Drug	Lidoflazine [3416-26-0]; Down 200; 8.2uM; PC3; HT_HG-U133A	ANK3 NUMA1 FRS3 AMBRA1 ZNF783 CEP68 GAS2L1 PHLDB1 PRPH	3.20e-05	199	181	9	5804_DN
Drug	Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; MCF7; HT_HG-U133A	CCNO ZBTB44 SLC12A9 BAZ2A MYO1F ZNF324 SRRM2 MAST3 PRPH	3.20e-05	199	181	9	2769_DN
Drug	Procaine hydrochloride [51-05-8]; Up 200; 14.6uM; MCF7; HT_HG-U133A	ZNF783 ADM CEP68 TDRD3 PLEKHG6 SLC12A9 MARK4 MYO1F PRPH	3.33e-05	200	181	9	1674_UP
Drug	Loperamide hydrochloride [34552-83-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A	MAST2 BRF1 SIPA1L1 MARK4 KAZN OTULINL DNM1 RIMS2 MAST3	3.33e-05	200	181	9	5632_DN
Drug	PKI166	RBMY1A1 RBMY1D RBMY1B RBMY1E FGF2	3.90e-05	48	181	5	CID006918403
Drug	azafagomine	INHA RBMY1A1 RBMY1D RBMY1B RBMY1E	9.00e-05	57	181	5	CID011957435
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	MAP2 BCORL1 RTN2 ADM MARK4 OTULINL PLK3 PRPH	9.24e-05	178	181	8	4388_UP
Drug	HPOP	CACNA1A SYNM TXNRD3	1.03e-04	12	181	3	CID000043677
Drug	AC1L2VU3	CACNA1A SYNM CACNA1G	1.03e-04	12	181	3	CID000129572
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	BCORL1 MTSS1 RTN2 ADM MARK4 CACNA1G MAST3 PRPH	1.04e-04	181	181	8	6276_UP
Drug	Rescinnamin [24815-24-5]; Up 200; 6.4uM; HL60; HT_HG-U133A	ZC3H13 NUMA1 CEP68 SIPA1L1 FGF2 SRRM2 CEP170B ADGRL3	1.25e-04	186	181	8	2130_UP
Drug	Metaraminol bitartrate [33402-03-8]; Up 200; 8.6uM; PC3; HT_HG-U133A	NUMA1 DENND1C PLXND1 MAST2 ZNF783 PHLDB1 LMNA BAZ2A	1.30e-04	187	181	8	7368_UP
Drug	Bacampicillin hydrochloride [37661-08-8]; Up 200; 8uM; HL60; HT_HG-U133A	SETD1A CAMK2G NUMA1 ZNF783 GAS2L1 BRF1 MTHFD2L USP6NL	1.56e-04	192	181	8	1337_UP
Drug	Nitrendipine [39562-70-4]; Up 200; 11uM; HL60; HT_HG-U133A	MTSS1 CHST8 BAZ2A SIPA1L1 CACNA1G LTBP1 USP6NL MTRF1L	1.56e-04	192	181	8	3087_UP
Drug	Furosemide [54-31-9]; Down 200; 12uM; MCF7; HT_HG-U133A	CAMK2G DVL3 CHST8 ZBTB44 BRF1 MAST4 MARK4 MAST3	1.62e-04	193	181	8	3197_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A	DVL3 SYNPO ZC3H3 ARHGAP22 PHLDB1 MAST4 SRRM2 INPP5J	1.62e-04	193	181	8	4322_UP
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	SETD1A PHLDB1 MAP7D1 PLEKHG6 BAZ2A LTBP1 SRRM2 INPP5J	1.62e-04	193	181	8	1667_DN
Drug	Y-27632; Up 200; 3uM; MCF7; HT_HG-U133A_EA	SETD1A DVL3 AMBRA1 TERT PHLDB1 PABPN1 CTDP1 PIGO	1.62e-04	193	181	8	948_UP
Drug	Cyclacillin [3485-14-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	DVL3 CCNO PLXND1 MAST2 ZNF783 MAST3 AGAP2 PRPH	1.62e-04	193	181	8	4536_UP
Drug	Etanidazole [22668-01-5]; Down 200; 18.6uM; MCF7; HT_HG-U133A	NUMA1 CCNO PHLDB1 LMNA SIPA1L1 MARK4 ZNF324 RIMS2	1.67e-04	194	181	8	6072_DN
Drug	Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A	MAP2 DVL3 SYNPO ZNF783 BAZ2A MYO1F MTRF1L MAST3	1.67e-04	194	181	8	4961_UP
Drug	PHA-00745360 [351320-33-7]; Down 200; 1uM; MCF7; HT_HG-U133A	MAP2 NUMA1 RTN2 BRF1 FGF2 RIMS2 PLK3 INPP5J	1.67e-04	194	181	8	3910_DN
Drug	Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A	GRB7 CEP68 TDRD3 MAST4 LMNA LTBP1 DNM1 SRRM2	1.67e-04	194	181	8	1707_DN
Drug	Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; MCF7; HT_HG-U133A	CCNO HDAC7 CHST8 CEP68 TDRD3 MAST4 MARK4 RIMS2	1.67e-04	194	181	8	6811_DN
Drug	H-7 dihydrochloride; Up 200; 100uM; MCF7; HT_HG-U133A	INHA DVL3 SYNPO MAST2 LMNA FGF2 CACNA1G AGAP2	1.67e-04	194	181	8	5936_UP
Drug	Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; MCF7; HT_HG-U133A	CCNO PHLDB1 FBXL18 MARK4 MYO1F ZNF324 PCDH7 PRPH	1.67e-04	194	181	8	5454_DN
Drug	Idoxuridine [54-42-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	CAMK2G AMBRA1 ZC3H3 PHLDB1 BAZ2A CTDP1 LTBP1 INPP5J	1.67e-04	194	181	8	1480_DN
Drug	Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A	GRB7 ZBTB44 MAST4 MARK4 RIMS2 SRRM2 MTRF1L MAST3	1.67e-04	194	181	8	4422_DN
Drug	Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; MCF7; HT_HG-U133A	CAMK2G CHST8 TDRD3 PHLDB1 PLEKHG6 LMNA BAZ2A PIGO	1.73e-04	195	181	8	3512_DN
Drug	(S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A	PRR36 CEP68 LMNA BAZ2A PABPN1 CTDP1 DNM1 PIGO	1.73e-04	195	181	8	3523_DN
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A	PRR36 HDAC7 PLEKHG6 LMNA MARK4 FGF2 MAST3 AGAP2	1.73e-04	195	181	8	2805_UP
Drug	Alfaxalone [23930-19-0]; Down 200; 12uM; HL60; HT_HG-U133A	MAST2 TDRD3 SLC12A9 SIPA1L1 MARK4 KAZN OTULINL PIGO	1.73e-04	195	181	8	3135_DN
Drug	Hydroflumethiazide [135-09-1]; Down 200; 12uM; MCF7; HT_HG-U133A	PRR36 PLXND1 MAST2 ZC3H3 TDRD3 MAST4 DNM1 SRRM2	1.73e-04	195	181	8	1687_DN
Drug	Thiamphenicol [15318-45-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A	ANK3 MAST2 ZNF783 MAST4 SLC12A9 MARK4 ZNF324 INPP5J	1.73e-04	195	181	8	7033_UP
Drug	Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A	PRR36 NUMA1 CCNO PHLDB1 LMNA BAZ2A LTBP1 PIGO	1.73e-04	195	181	8	1688_DN
Drug	Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; MCF7; HT_HG-U133A	CAMK2G DVL3 CEP68 LMNA KAZN PCDH7 PIGO MAST3	1.73e-04	195	181	8	1527_DN
Drug	Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; MCF7; HT_HG-U133A	ZNF783 TDRD3 MAST4 SLC12A9 MARK4 DNM1 PLK3 PRPH	1.73e-04	195	181	8	2852_DN
Drug	Ozagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; MCF7; HT_HG-U133A	ZC3H3 ADM PHLDB1 BAZ2A CTDP1 ZNF324 PIGO MAP3K2	1.73e-04	195	181	8	3503_DN
Drug	Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A	BCAS3 CAMK2G MEX3D TATDN2 MAST4 FBXL18 ZNF324 SRRM2	1.80e-04	196	181	8	2056_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	PRR36 DVL3 CCNO RTN2 ZBTB44 MAST4 BAZ2A MARK4	1.80e-04	196	181	8	5604_DN
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A	DVL3 GRB7 BRF1 PABPN1 EIF4G1 CTDP1 ZNF324 KAZN	1.80e-04	196	181	8	4834_DN
Drug	Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; PC3; HT_HG-U133A	CACNA1A CCNO HDAC7 ZNF783 CEP68 SLC12A9 BAZ2A OTULINL	1.80e-04	196	181	8	6619_DN
Drug	Mimosine [500-44-7]; Down 200; 20.2uM; PC3; HT_HG-U133A	FRS3 LRRK1 CEP68 PLEKHG6 BAZ2A MARK4 MYO1F ADGRL3	1.80e-04	196	181	8	6703_DN
Drug	0198306-0000 [212631-61-3]; Up 200; 10uM; PC3; HT_HG-U133A	ANK3 FRS3 CCNO ZBTB44 TDRD3 BRF1 MARK4 PIGO	1.80e-04	196	181	8	7102_UP
Drug	Gemfibrozil [25812-30-0]; Up 200; 16uM; MCF7; HT_HG-U133A	PRR36 MTSS1 NUMA1 MAST2 CHST8 MAST4 MARK4 CTDP1	1.80e-04	196	181	8	5488_UP
Drug	PHA-00851261E [724719-49-7]; Down 200; 10uM; MCF7; HT_HG-U133A	PRR36 CCNO MAST2 TDRD3 LMNA MARK4 PCDH7 MTRF1L	1.80e-04	196	181	8	3965_DN
Drug	Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; HL60; HT_HG-U133A	CDV3 LRRK1 PLXND1 ZC3H3 ZBTB44 TDRD3 SLC12A9 ZNF324	1.80e-04	196	181	8	2351_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	DVL3 MAST2 RTN2 ADM ZBTB44 PHLDB1 MAST4 PRPH	1.80e-04	196	181	8	5563_DN
Drug	Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ZC3H3 CEP68 BRF1 MAST4 MARK4 KAZN MAST3 PRPH	1.80e-04	196	181	8	2889_DN
Drug	Mefenamic acid [61-68-7]; Up 200; 16.6uM; PC3; HT_HG-U133A	FRS3 GRB7 SYNPO BRF1 MAST4 PLEKHG6 LMNA AGAP2	1.80e-04	196	181	8	5109_UP
Drug	Alcuronium chloride [15180-03-7]; Down 200; 5.4uM; MCF7; HT_HG-U133A	SYNM CAMK2G ADM MAST4 SIPA1L1 RIMS2 PLK3 MAST3	1.80e-04	196	181	8	4409_DN
Drug	Alfadolone acetate [23930-37-2]; Down 200; 10.2uM; HL60; HT_HG-U133A	CAMK2G LRRK1 CEP68 BAZ2A MARK4 KAZN PLK3 CEP170B	1.86e-04	197	181	8	3127_DN
Drug	Tubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; MCF7; HT_HG-U133A	PRR36 ZNF783 CHST8 MAST4 FBXL18 MARK4 ZNF324 INPP5J	1.86e-04	197	181	8	5449_DN
Drug	Dydrogesterone [152-62-5]; Down 200; 12.8uM; MCF7; HT_HG-U133A	CDV3 CAMK2G DVL3 HDAC7 CHST8 PHLDB1 LMNA PABPN1	1.86e-04	197	181	8	4836_DN
Drug	Indoprofen [31842-01-0]; Up 200; 14.2uM; MCF7; HT_HG-U133A	SETD1A PRR36 NUMA1 SYNPO TERT SLC12A9 FGF2 PIGO	1.86e-04	197	181	8	4832_UP
Drug	Josamycin [16846-24-5]; Down 200; 4.8uM; PC3; HT_HG-U133A	CACNA1A LRRK1 ZNF783 HEYL MYO1F PCDH7 ADGRL3 MAST3	1.86e-04	197	181	8	4631_DN
Drug	Sulfameter [651-06-9]; Up 200; 14.2uM; HL60; HT_HG-U133A	MTSS1 GRB7 LMNA CACNA1G RIMS2 ADGRL3 AGAP2 PRPH	1.86e-04	197	181	8	2712_UP
Drug	fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	CAMK2G DVL3 PLXND1 CEP68 MAST4 PCDH7 PLK3 MAST3	1.86e-04	197	181	8	5597_DN
Drug	Skimmianine [83-95-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	FRS3 LRRK1 PHLDB1 MARK4 MTHFD2L ZNF324 PIGO MAST3	1.86e-04	197	181	8	5766_DN
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A	SETD1A CCNO GRB7 MAST2 TDRD3 PHLDB1 SLC12A9 MARK4	1.86e-04	197	181	8	7440_DN
Drug	Tyloxapol [25301-02-4]; Down 200; 4uM; MCF7; HT_HG-U133A	NUMA1 CCNO TDRD3 FBXL18 LMNA SIPA1L1 ZNF324 PRPH	1.86e-04	197	181	8	5672_DN
Drug	Brinzolamide [138890-62-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A	ZC3H13 CCNO ZNF783 MARK4 SRRM2 PCDH7 ADAMTSL4 MAST3	1.86e-04	197	181	8	5016_UP
Drug	Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A	NUMA1 CHST8 CEP68 TDRD3 BRF1 BAZ2A SIPA1L1 LTBP1	1.86e-04	197	181	8	7037_DN
Drug	clozapine; Down 200; 10uM; MCF7; HT_HG-U133A	CAMK2G PHLDB1 MAST4 LMNA BAZ2A MARK4 MYO1F PLK3	1.86e-04	197	181	8	5589_DN
Drug	Ceforanide [60925-61-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A	CAMK2G DVL3 MAST2 FBXL18 PLEKHG6 LMNA MARK4 MAST3	1.86e-04	197	181	8	3309_DN
Disease	triacylglycerol 48:1 measurement	NYAP2 LMNA ERC2 RNF32-DT	2.74e-06	17	176	4	EFO_0010404
Disease	triacylglycerol 50:2 measurement	NYAP2 LMNA ERC2 RNF32-DT	3.39e-05	31	176	4	EFO_0010409
Disease	ischemic cardiomyopathy	KIF26B LMNA	1.06e-04	3	176	2	EFO_0001425
Disease	monocyte percentage of leukocytes	ATF7 NYAP2 ZC3H18 EBF1 RUFY1 TERT GLCCI1 FBXL18 CSNK1D MARK4 MYO1F CTDP1 C3AR1 SSH2	1.34e-04	731	176	14	EFO_0007989
Disease	mean arterial pressure	NYAP2 EBF1 TERT HDAC7 SLC12A9 KIAA1217 MARK4 PKHD1 MTX1 LNX1 RNF32-DT	2.17e-04	499	176	11	EFO_0006340
Disease	triglyceride measurement, alcohol drinking	NYAP2 EBF1 HEYL SP6 TP53BP1	3.24e-04	99	176	5	EFO_0004329, EFO_0004530
Disease	Progeria	ANK3 LMNA	3.50e-04	5	176	2	C0033300
Disease	triglyceride measurement, alcohol consumption measurement	NYAP2 EBF1 HEYL SP6 TP53BP1	3.56e-04	101	176	5	EFO_0004530, EFO_0007878
Disease	ergothioneine measurement	CACNA1A RIMS2 LNX1	4.90e-04	26	176	3	EFO_0021163
Disease	myeloid white cell count	BICD2 ATF7 EBF1 LRRK1 MAST2 TERT CIT HDAC7 GLCCI1 LMNA MARK4 MTHFD2L CDT1 SSH2 TNS3	5.23e-04	937	176	15	EFO_0007988
Disease	neutrophil count	BICD2 CACNA1A ATF7 BCORL1 ISM2 MAST2 TERT CIT GLCCI1 KLF16 LMNA MARK4 ANKRD34A MTHFD2L C3AR1 SSH2 LNX1 MTRF1L TNS3	6.28e-04	1382	176	19	EFO_0004833
Disease	Alzheimer disease	ANK3 BCAS3 WDR81 KLF16 MARK4 SP6 PKHD1 FMN2 CACNA1G PCDH7	7.03e-04	485	176	10	MONDO_0004975
Disease	neuroimaging measurement	ANK3 MAP2 KIF26B CAMK2G PLXND1 RUFY1 GLCCI1 ARHGAP22 MAST4 PKHD1 ERC2 SSH2 LNX1 PCDH7 EIF2AK3 WNK2	7.03e-04	1069	176	16	EFO_0004346
Disease	Uterine leiomyoma, breast carcinoma	TERT DLEU7 EIF2AK3	9.11e-04	32	176	3	EFO_0000305, HP_0000131
Disease	triglycerides to total lipids in small HDL percentage	NYAP2 HEYL SP6 TP53BP1	9.17e-04	72	176	4	EFO_0022336
Disease	Agents acting on the renin-angiotensin system use measurement	NYAP2 BCAS3 EBF1 HDAC7 CEP68 SP6 PKHD1 ERC2	9.49e-04	335	176	8	EFO_0009931
Disease	prostate carcinoma	DAB2IP LINC00472 MAST2 TERT EZHIP KLF16 DLGAP3 MAST4 LMNA SP6 PKHD1 PLEKHH2 ADAMTSL4 TNS3	9.59e-04	891	176	14	EFO_0001663
Disease	X-linked infantile spasms	CAMK2G DNM1	9.67e-04	8	176	2	C4552072
Disease	autosomal recessive intellectual developmental disorder (implicated_via_orthology)	CNTNAP3B CNTNAP3	9.67e-04	8	176	2	DOID:0060308 (implicated_via_orthology)
Disease	hematocrit	SLAIN2 NYAP2 BCAS3 BCORL1 SYNPO EBF1 MAST2 TERT MARK4 PKHD1 DLEU7 CDT1 SSH2 MTX1 TP53BP1	1.13e-03	1011	176	15	EFO_0004348
Disease	neutrophil percentage of leukocytes	ATF7 NYAP2 ZC3H18 EBF1 ISM2 TERT HDAC7 GLCCI1 MARK4 FGF2 C3AR1	1.15e-03	610	176	11	EFO_0007990
Disease	cortical surface area measurement	BICD2 CACNA1A NYAP2 ANK3 MAP2 KIF26B ZC3H13 EBF1 PLXND1 MAST2 MAST4 PKHD1 ERC2 SSH2 LNX1 PCDH7 RNF32-DT WNK2	1.18e-03	1345	176	18	EFO_0010736
Disease	gluteofemoral adipose tissue measurement	NYAP2 EBF1 PLXND1 PKHD1 FGF2	1.20e-03	132	176	5	EFO_0803317
Disease	Focal Segmental Glomerulosclerosis, Not Otherwise Specified	SYNPO LMNA	1.24e-03	9	176	2	C4049702
Disease	cholesterol in large HDL measurement	NYAP2 HEYL SP6 TP53BP1	1.36e-03	80	176	4	EFO_0021900
Disease	epilepsy	MAST4 PCDH7 ADGRL3	1.88e-03	41	176	3	EFO_0000474
Disease	interleukin 2 measurement	BCAS3 EBF1 KAZN	1.88e-03	41	176	3	EFO_0008331
Disease	platelet component distribution width	NYAP2 MTSS1 HDAC7 JMY CEP68 METTL24 BRF1 MAVS BAZ2A MARK4 DLEU7 DNM1	2.00e-03	755	176	12	EFO_0007984
Disease	gastric carcinoma	TATDN2 TERT LMNA MTX1	2.01e-03	89	176	4	EFO_0000178
Disease	Malignant neoplasm of breast	BCORL1 SPATA18 DVL3 GRB7 RUFY1 TERT HDAC7 HEYL CSNK1D SIPA1L1 MKI67 ANKRD34A NHS TP53BP1 AGAP2	2.03e-03	1074	176	15	C0006142
Disease	BMI-adjusted waist-hip ratio, sex interaction measurement	NYAP2 PLXND1 SP6	2.16e-03	43	176	3	EFO_0007788, EFO_0008343
Disease	coronary artery disease	DAB2IP NYAP2 BCAS3 FTMT FNDC1 MAST4 KIAA1217 MARK4 SP6 PKHD1 FMN2 PLEKHH2 LNX1 ADGRL3 WNK2 TNS3	2.19e-03	1194	176	16	EFO_0001645
Disease	dimethylglycine measurement	ZC3H13 JMY CACNA1G	2.62e-03	46	176	3	EFO_0010476
Disease	sexual dimorphism measurement	LRRC66 NYAP2 ENTR1 SPATA18 FRS3 LINC00472 HEYL SSC5D MYO1F SP6 DLEU7 ERC2 LTBP1 TP53BP1 AGAP2	2.68e-03	1106	176	15	EFO_0021796
Disease	cortical thickness	NYAP2 EBF1 PLXND1 MAST2 RUFY1 PHLDB1 MAST4 PKHD1 FMN2 ERC2 SSH2 LNX1 PCDH7 RNF32-DT WNK2	2.85e-03	1113	176	15	EFO_0004840
Disease	alcohol consumption measurement, high density lipoprotein cholesterol measurement	NYAP2 EBF1 HEYL SP6 TP53BP1	2.93e-03	162	176	5	EFO_0004612, EFO_0007878
Disease	corpus callosum volume measurement	SCHIP1 KIF26B LNX1 WNK2	3.07e-03	100	176	4	EFO_0010299
Disease	Colorectal Carcinoma	SHANK1 CCDC9B DONSON MAP2 KCNH4 CHST8 BRF1 EIF4G1 MKI67 PKHD1 PIGO	3.40e-03	702	176	11	C0009402
Disease	alcohol drinking, high density lipoprotein cholesterol measurement	NYAP2 EBF1 HEYL SP6 TP53BP1	3.43e-03	168	176	5	EFO_0004329, EFO_0004612
Disease	cerebellar volume measurement	EBF1 EIF2AK3 RNF32-DT	3.72e-03	52	176	3	EFO_0020864
Disease	immature platelet count	TERT STK35 BRF1 MARK4	3.79e-03	106	176	4	EFO_0803544
Disease	abdominal adipose tissue measurement	NYAP2 SP6 PKHD1	3.93e-03	53	176	3	EFO_0803316
Disease	hair colour measurement	NYAP2 DOCK8-AS1 ZC3H18 SLC12A9 SP6 PKHD1 FMN2 CDT1 LNX1 RNF32-DT	3.99e-03	615	176	10	EFO_0007822
Disease	leptin measurement, type 2 diabetes mellitus	NYAP2 SP6	4.02e-03	16	176	2	EFO_0005000, MONDO_0005148
Disease	granulocyte count	MAST2 TERT GLCCI1 MARK4 MTHFD2L TNS3	4.31e-03	254	176	6	EFO_0007987
Disease	urinary albumin to creatinine ratio	NYAP2 NUMA1 WDR81 DLEU7 KAZN	4.48e-03	179	176	5	EFO_0007778
Disease	body fat percentage, type 2 diabetes mellitus	NYAP2 SP6	4.54e-03	17	176	2	EFO_0007800, MONDO_0005148
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	CAMK2G SRRM2	4.54e-03	17	176	2	DOID:0060307 (is_implicated_in)
Disease	insulin measurement	NYAP2 AMBRA1 FTMT EBF1 HDAC7 SP6	5.47e-03	267	176	6	EFO_0004467
Disease	total blood protein measurement	NYAP2 EBF1 LRRK1 TERT MARK4 PKHD1 DLEU7 ROCK1	5.72e-03	449	176	8	EFO_0004536
Disease	brain measurement, neuroimaging measurement	ANK3 MAP2 KIF26B MAST4 ERC2 SSH2 LNX1 RNF32-DT WNK2	5.96e-03	550	176	9	EFO_0004346, EFO_0004464

Protein segments in the cluster

Peptide	Gene	Start	Entry
SPSRTLSPGRRAKSR	PRPF4B	381	Q13523
PSTSGTSTPRRGRRQ	CACNA1A	2271	O00555
PSLSARAQRAGPRAS	nan	51	P0DMU3
PGTRRERTLGAPASS	CTDP1	891	Q9Y5B0
RATPRGPTLLRTLGT	FAM246A	171	A0A494C0Y3
RAAPRGPTLLRTLGT	FAM246B	171	A0A494C0N9
ARPSPSPTGGRALRF	CCDC61	331	Q9Y6R9
AALRPSGPSRVTVRG	CNTNAP3	1181	Q9BZ76
RSPPRSELSLISSRG	ADAMTSL4	176	Q6UY14
RTSPGGRTSPEARGR	BICD2	566	Q8TD16
GRFLTSAPRGLTPVA	CXorf49;	256	A8MYA2
QLASTPRAPGSRDAR	CEP68	396	Q76N32
PTSPSSPAARAGRRD	CCNO	6	P22674
RTVAAGRARGLPAPT	EIF2AK3	26	Q9NZJ5
TASSPARARGRPRKT	BAZ2A	1181	Q9UIF9
RRPSILPEGSSDSRG	ARHGEF5	1041	Q12774
VPSSRRGSSTERPQL	BCORL1	1026	Q5H9F3
PGRSTTPSVSGRRNR	ADGRL3	451	Q9HAR2
ASATSGSRKRARPPA	CDT1	41	Q9H211
PSPRRRSSAASVGRA	AGAP2	1171	Q99490
TSLRAPRTQRTPGRS	ARMC5	496	Q96C12
RRSSSPERRSPGSPV	GLCCI1	136	Q86VQ1
SPAQPTPSTGGRRRR	ATF7	311	P17544
TRRSLGGPLSSHPSR	AMBRA1	391	Q9C0C7
PASRTPARPFGSVGR	CEP170B	481	Q9Y4F5
TTTGPRQPFSRARSG	CEP170B	1226	Q9Y4F5
PRAGSSSRARSRAPG	CEP170B	1286	Q9Y4F5
SSRARSRAPGPRDTD	CEP170B	1291	Q9Y4F5
QRGGSLRAPALPSRS	DENND1C	476	Q8IV53
SSLRGPRERAPSERS	DVL3	611	Q92997
ATDSPRRPSRCTGGV	BCAS3	6	Q9H6U6
RPSADSLPRGSARLT	C3AR1	236	Q16581
SGLMSPSRLPGSRER	CAMSAP3	1076	Q9P1Y5
SGVYRPPGARLTTTR	CDV3	166	Q9UKY7
RRLRGSGSPSRPSLT	CDAN1	151	Q8IWY9
SPGRMLSTRRERSPG	CIT	1981	O14578
SSRGRLPAGAVRTPL	CIT	2001	O14578
RRSLPEAGPGRTLVS	ADM	151	P35318
TGRPRLSRRHSTEGP	ANKRD34A	281	Q69YU3
SLPGAVSPLSGRRRS	ANKRD34A	386	Q69YU3
SPAPAPRTASASRRR	RNF32-DT	26	Q8NI28
PPASSRNRSPSGSLR	RBMY1A1	96	P0DJD3
PPASSRNRSPSGSLR	RBMY1B	96	A6NDE4
PPASSRNRSPSGSLR	RBMY1C	96	P0DJD4
PPASSRNRSPSGSLR	RBMY1D	96	P0C7P1
PPASSRNRSPSGSLR	RBMY1E	96	A6NEQ0
PPASSRNRSPSGSLR	RBMY1F	96	Q15415
ERPGSRRSLPGSLSE	DAB2IP	46	Q5VWQ8
SVSPGRTIRSAPAVG	OTOP3	21	Q7RTS5
TSVSRPGRGEPRFIS	HLA-E	31	P13747
RLRLSPSPTSQRSRG	LMNA	386	P02545
ERFGTPPGRASSVTR	KAZN	691	Q674X7
LLRRPGARSTSPSDS	KLF16	216	Q9BXK1
PGRLRTGSRAPTAEA	MED14OS	26	P0DP75
ARSTPRASRLPGPTG	MAVS	231	Q7Z434
PRDPTRSSGSRTLLL	GLTPD2	171	A6NH11
PRSTRSLLGDPRLRS	JMY	116	Q8N9B5
VSTAPARRSGPPRAR	DLEU7	46	Q6UYE1
PSTRGGDPAARSRRT	LRRK1	41	Q38SD2
GRRSPTSSPTPQRRA	DNM1	771	Q05193
TSVGSRPPAVRGSRD	FSD1L	351	Q9BXM9
SSLRRGRSQPPCSEG	KIF12	621	Q96FN5
QGRSSRSRSPSPAPR	SPATA18	251	Q8TC71
SRLLLASPRARGPSA	KIF26B	1736	Q2KJY2
ASALRRRASGPGPVI	EZHIP	221	Q86X51
PQETRSGSRRTSPGV	GDF1	71	P27539
LAPRSRPTRGGSQRS	CCDC9B	501	Q6ZUT6
GPRPGSLTRLAEVSA	ISM2	36	Q6H9L7
ITAISPRRSPVSGGR	PLXND1	1071	Q9Y4D7
APSRASPGVPSERTR	LTBP1	71	Q14766
TPRVTSRSGPAPARR	DLAT	31	P10515
RTPSTKPSVRRGTIG	MTSS1	591	O43312
LTLRVRDGGDPPRSS	PCDH7	276	O60245
PSSSVRLGSFRSPRA	PRPH	51	P41219
PATRGLPSTASGRLR	CSNK1D	321	P48730
RLSIIGPTSRDRSSP	MAP3K2	151	Q9Y2U5
RRPPTATAGLRGDTA	MEX3D	381	Q86XN8
SRSPRLSQPRSESLG	KCNH4	701	Q9UQ05
SPVDSGRSNRTRARP	LNX1	196	Q8TBB1
PTTGSDGRPDARVRL	DPP3	591	Q9NY33
PARRNVLPSRGASST	HEYL	231	Q9NQ87
VLPSRGASSTRRARP	HEYL	236	Q9NQ87
GASSTRRARPLERPA	HEYL	241	Q9NQ87
APGPSTLRPAATARR	HRES1	146	P13985
LPRSPRLGHRRTSSG	ERC2	21	O15083
PAASVTGSRRRPRAP	MKI67	2776	P46013
GPRRTSLPRDSSLSQ	NYAP2	216	Q9P242
GPGPRAALSRSASVR	TAMALIN	321	Q7Z6J2
GPSSARGLLPRDASR	GRB7	86	Q14451
SRSRSGPGSPRAMKR	PLEKHH2	641	Q8IVE3
PDRTLGRSRKDPGSS	LRRC66	471	Q68CR7
RPRSRSLSPGRSPSS	MAST1	156	Q9Y2H9
SPTRARERERSGAPA	OTULINL	6	Q9NUU6
QTSPSSTPVAGRRGR	RIMS2	1146	Q9UQ26
GTPTGSRSPLSRLRQ	PLEKHG6	596	Q3KR16
RPGISTTDRGFPRAR	PABPN1	251	Q86U42
SAGRRDAARPSRPRS	LINC00472	66	Q9H8W2
SSAGSTGRIPGLRRL	HECTD1	341	Q9ULT8
GLRRAPPRTRMDSSG	DOCK8-AS1	81	Q5T8R8
PKSPRGRVRARSSDG	DOCK8-AS1	191	Q5T8R8
APSLKRRSPSGERRS	CACNA1G	1116	O43497
RRPGATPLSRARSLA	ENTR1	6	Q96C92
APDSSRTPGLSRSRD	UPB1	321	Q9UBR1
SDDTGTGPRRERPSR	GAS2L1	371	Q99501
RSHGSFPVPLTRRRG	FRS3	381	O43559
SRDAGRSPSQPRLSL	FNDC1	1021	Q4ZHG4
ERGSRSLPDSGRASP	DLGAP3	776	O95886
RRNSSERTLSPGLPS	HUNK	591	P57058
RSSRRTGPQSPCERT	ANK3	4076	Q12955
GRRARRLDPSEGTPS	EBF1	241	Q9UH73
ANLGRTTLSTRGPPR	EIF4G1	671	Q04637
PPSGERSRLARGSTI	MARK4	551	Q96L34
SPRGTTASPKGRVRR	MAP7D1	496	Q3KQU3
RSRSLSPGRSPVSFD	MAST2	296	Q6P0Q8
PRSRSLSPGRATGTF	MAST3	151	O60307
RGPPTARSERSAARA	MAST4	1976	O15021
ARSRGAAASPPRELT	DONSON	26	Q9NYP3
TRPPSGGERARRSTP	INHA	221	P05111
PSVNPRSRAAGSPRT	FGF2	51	P09038
RPPGPAASSSARRSQ	KLHDC7B	111	Q96G42
RRGPRASVTNDSGPR	ELP4	31	Q96EB1
DSGPRLVSIAGTRPS	ELP4	41	Q96EB1
LRRRPAETLGDSSPS	HDAC7	186	Q8WUI4
RPEPSLSRGSRTALA	FMN2	446	Q9NZ56
GRVPEGRSSRDRTAP	CAMK2G	396	Q13555
AALRPSGPSRVTVRG	CNTNAP3B	1181	Q96NU0
RRPLAAAASSRDPTG	FTMT	46	Q8N4E7
SSRRPLRGPAASGRE	MLNR	276	O43193
ASPNTRSGTRRSPRI	NUMA1	2076	Q14980
PRPSTVSGSRRAPER	PCARE	576	A6NGG8
SRARRSLASPGISPG	MTX1	101	Q13505
AELRRAGPGSPTRSA	METTL24	31	Q5JXM2
STARRPRPQGRSVSE	RTN2	81	O75298
SRGPPAKSQRRTRST	THAP8	86	Q8NA92
SPATAKRGRSRSRTP	SRRM2	486	Q9UQ35
TPLRQRSRSGSSPEV	SRRM2	1571	Q9UQ35
RTARRGSRSSPEPKT	SRRM2	1666	Q9UQ35
GLPRNRGSERPSTSS	TDRD3	351	Q9H7E2
RSASRSGGPSSPKRL	TATDN2	41	Q93075
QSPRNSPRSRSPARG	SLAIN2	356	Q9P270
RESLSRQRSPAPGSP	SYNM	1036	O15061
SASARVGRSRAPPAA	NHS	1596	Q6T4R5
RSPAREPGDVSARTR	SCHIP1	116	P0DPB3
RRAVGPARRPLSSGS	MTRF1L	16	Q9UGC7
GAFRVASRSPARTPP	SYNPO	771	Q8N3V7
RSGIALRAARPPGSS	PRDM15	71	P57071
RSQLPGPGDLRSATR	RUFY1	41	Q96T51
PSARTSRATGRRQPC	FBXL18	686	Q96ME1
SPARSGPSARGTPRA	PRR36	251	Q9H6K5
RRREAPAPSSGTPIA	FBXL22	126	Q6P050
ILERRASRPGTPTSS	PHF12	156	Q96QT6
SSDGRPLERRLSPGS	SIPA1L1	1116	O43166
APTPFSRGSRTRASL	KIAA1217	156	Q5T5P2
LTSTDRAPSNPRGGR	PKHD1	3226	P08F94
GPRLPFSRSRLSLGA	TMEM151A	396	Q8N4L1
RPKGSRRSVPRSSGQ	SP6	211	Q3SY56
SRNPEGSRTLSPSRG	STARD9	2931	Q9P2P6
TTRRPGSSSPAIRRL	SSC5D	911	A1L4H1
RASSRLPDTGEGPSR	TNS3	741	Q68CZ2
VRTSPRPASPARSGS	SETD1A	456	O15047
VAVLSRTAPTGPGSR	ARHGAP22	401	Q7Z5H3
SRRGLSSPRLSLAPA	ROBO4	626	Q8WZ75
LRSASSPRGARARSP	SHANK1	486	Q9Y566
RQPRGRPSSSGTPRE	SHANK1	511	Q9Y566
TRDLSSGAPRGRNLP	CHST8	76	Q9H2A9
AARVGRPVLSPRTSG	PAK6-AS1	46	Q8N910
PSSRERRGASRSPSP	INPP5J	901	Q15735
GSSASRPVPASRGRK	TBC1D3B	366	A6NDS4
RSSPRLNKGRSPATG	ZNF767P	116	Q75MW2
RTSSRALVPGGSPRG	VSX1	11	Q9NZR4
TSDPGRLITDPRSGR	PLK3	46	Q9H4B4
PGSRPQTRRSCSGDL	USP51	156	Q70EK9
ATSRAARSRRQPGPG	STK35	61	Q8TDR2
SVGRPSPLASGRRES	USP6NL	391	Q92738
AEEAGLRSRTRPSSP	TAS1R3	46	Q7RTX0
GSVGDSPREPRRTVS	ZC3H3	206	Q8IXZ2
RGASPSRERKPTGVS	ZNF324	126	O75467
SSPRSASGRLRGPRP	nan	56	P0C879
LPRGNGSSTPRISHR	SSH2	51	Q76I76
SRTGSPELAARARPR	IGSF9B	1211	Q9UPX0
GSGSPRDTRPLSTQR	PLCH2	981	O75038
SLGPPRTREDGSRIS	WASH4P	51	A8MWX3
RASGALPPERLSRGS	SLC12A9	701	Q9BXP2
TRTLELPGPSETGRR	ZBTB44	251	Q8NCP5
SGRAPRRASSGLPRN	STOML2	21	Q9UJZ1
RGRPPSRTTGTRETA	TP53BP1	1401	Q12888
SRPSGARSESPRLSR	PHLDB1	301	Q86UU1
ARGRRTRSPSPTLGE	PHLDB1	511	Q86UU1
SRRRTPASRSGADPV	BRF1	571	Q92994
GRAPALGRSTAPSVR	MTHFD2L	16	Q9H903
QSPGRSSVASPRRLS	MAP2	1781	P11137
PSGFVRASPRTLSTR	ROCK1	1321	Q13464
PRTSRGALSPSLGRL	ZNF252P-AS1	66	Q0IIN9
RRARLSSPGPSRSSE	TXNRD3	36	Q86VQ6
AGAPRTRTVLTPFSG	PIGO	771	Q8TEQ8
RGRVSPDGTRTPAVT	TRMT12	176	Q53H54
LSVPTPDGALGTARR	WNK2	2241	Q9Y3S1
ARRRGGSASRSLPLP	TERT	221	O14746
PGLVRALAISPSGRS	WDR81	1786	Q562E7
LRSSRSSPPRAAGHR	nan	231	A6NL46
RGRRLSPRTGAPGTT	nan	56	Q8N7P7
GRRLSPQTGTPRTTA	nan	91	Q8N7P7
SRGRRLSPQTGTPGT	nan	191	Q8N7P7
GRRLSPQTGTPRTTA	nan	261	Q8N7P7
SRRPSVFERLGPSTG	ZC3H13	21	Q5T200
AGPRRTRESRPGAVS	ZNF785	16	A8K8V0
RTPPRRRTLSGSGSG	ZC3H18	676	Q86VM9
PGASGETPRVLSRRR	ZNF783	331	Q6ZMS7
FVGRSTGTRAPPLTR	KIAA1522	246	Q9P206
STSLGASRRPRARPP	MYO1F	986	O00160